JPWO2006014028A1 - Sweet potato stem and leaf extract and use thereof - Google Patents
Sweet potato stem and leaf extract and use thereof Download PDFInfo
- Publication number
- JPWO2006014028A1 JPWO2006014028A1 JP2006531750A JP2006531750A JPWO2006014028A1 JP WO2006014028 A1 JPWO2006014028 A1 JP WO2006014028A1 JP 2006531750 A JP2006531750 A JP 2006531750A JP 2006531750 A JP2006531750 A JP 2006531750A JP WO2006014028 A1 JPWO2006014028 A1 JP WO2006014028A1
- Authority
- JP
- Japan
- Prior art keywords
- sweet potato
- extract
- water
- polyphenol
- foliage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000017020 Ipomoea batatas Species 0.000 title claims abstract description 375
- 235000002678 Ipomoea batatas Nutrition 0.000 title claims abstract description 375
- 239000000284 extract Substances 0.000 title claims abstract description 361
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 151
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 149
- 238000010521 absorption reaction Methods 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 51
- 230000009102 absorption Effects 0.000 claims abstract description 50
- 238000004519 manufacturing process Methods 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 42
- 235000000346 sugar Nutrition 0.000 claims abstract description 36
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 33
- 230000007935 neutral effect Effects 0.000 claims abstract description 30
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 27
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 27
- 235000013376 functional food Nutrition 0.000 claims abstract description 23
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 22
- 230000005764 inhibitory process Effects 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 191
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 84
- 239000003925 fat Substances 0.000 claims description 69
- 235000019197 fats Nutrition 0.000 claims description 64
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims description 48
- 238000000605 extraction Methods 0.000 claims description 46
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 claims description 46
- 235000013305 food Nutrition 0.000 claims description 41
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 claims description 40
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 claims description 40
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 claims description 39
- 239000003921 oil Substances 0.000 claims description 31
- 239000003960 organic solvent Substances 0.000 claims description 31
- 239000004480 active ingredient Substances 0.000 claims description 30
- 235000019198 oils Nutrition 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 28
- 239000000047 product Substances 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 208000008589 Obesity Diseases 0.000 claims description 17
- 244000269722 Thea sinensis Species 0.000 claims description 17
- 239000000935 antidepressant agent Substances 0.000 claims description 17
- 229940005513 antidepressants Drugs 0.000 claims description 17
- 210000004185 liver Anatomy 0.000 claims description 17
- 235000020824 obesity Nutrition 0.000 claims description 17
- 230000001430 anti-depressive effect Effects 0.000 claims description 16
- 230000006866 deterioration Effects 0.000 claims description 16
- 235000013616 tea Nutrition 0.000 claims description 16
- 230000002265 prevention Effects 0.000 claims description 15
- 230000002929 anti-fatigue Effects 0.000 claims description 13
- 239000012223 aqueous fraction Substances 0.000 claims description 13
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 12
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 12
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 11
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 11
- 229940074393 chlorogenic acid Drugs 0.000 claims description 11
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 11
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 11
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 11
- 235000013361 beverage Nutrition 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- KRZBCHWVBQOTNZ-PSEXTPKNSA-N 3,5-di-O-caffeoyl quinic acid Chemical compound O([C@@H]1C[C@](O)(C[C@H]([C@@H]1O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 KRZBCHWVBQOTNZ-PSEXTPKNSA-N 0.000 claims description 9
- MVCIFQBXXSMTQD-UHFFFAOYSA-N 3,5-dicaffeoylquinic acid Natural products Cc1ccc(C=CC(=O)OC2CC(O)(CC(OC(=O)C=Cc3ccc(O)c(O)c3)C2O)C(=O)O)cc1C MVCIFQBXXSMTQD-UHFFFAOYSA-N 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 9
- 239000002781 deodorant agent Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 230000006870 function Effects 0.000 claims description 7
- 235000021067 refined food Nutrition 0.000 claims description 7
- 239000003651 drinking water Substances 0.000 claims description 6
- 235000020188 drinking water Nutrition 0.000 claims description 6
- 235000012149 noodles Nutrition 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 235000015872 dietary supplement Nutrition 0.000 claims description 5
- 235000015203 fruit juice Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000015110 jellies Nutrition 0.000 claims description 5
- 239000008274 jelly Substances 0.000 claims description 5
- 229940127557 pharmaceutical product Drugs 0.000 claims description 5
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 4
- 230000003449 preventive effect Effects 0.000 claims description 4
- 235000013322 soy milk Nutrition 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 235000013618 yogurt Nutrition 0.000 claims description 4
- 239000004278 EU approved seasoning Substances 0.000 claims description 3
- 235000008429 bread Nutrition 0.000 claims description 3
- 235000013353 coffee beverage Nutrition 0.000 claims description 3
- 235000011194 food seasoning agent Nutrition 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 235000014214 soft drink Nutrition 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 34
- 239000003112 inhibitor Substances 0.000 abstract description 16
- 239000002994 raw material Substances 0.000 abstract description 11
- 101710147108 Tyrosinase inhibitor Proteins 0.000 abstract description 8
- 230000002443 hepatoprotective effect Effects 0.000 abstract description 7
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 abstract description 5
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 68
- 210000004369 blood Anatomy 0.000 description 33
- 239000008280 blood Substances 0.000 description 33
- 230000009471 action Effects 0.000 description 31
- 239000000243 solution Substances 0.000 description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 241000700159 Rattus Species 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- 241001465754 Metazoa Species 0.000 description 19
- 210000001789 adipocyte Anatomy 0.000 description 18
- 235000006708 antioxidants Nutrition 0.000 description 18
- -1 Polyphenol compounds Chemical class 0.000 description 16
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 238000005259 measurement Methods 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 238000000746 purification Methods 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 239000002244 precipitate Substances 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 238000003809 water extraction Methods 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 12
- 206010020880 Hypertrophy Diseases 0.000 description 11
- 229940094952 green tea extract Drugs 0.000 description 11
- 235000020688 green tea extract Nutrition 0.000 description 11
- 230000004069 differentiation Effects 0.000 description 10
- 239000002504 physiological saline solution Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 9
- 235000005487 catechin Nutrition 0.000 description 9
- 230000001877 deodorizing effect Effects 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000004811 liquid chromatography Methods 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 7
- 241000508269 Psidium Species 0.000 description 7
- 239000003463 adsorbent Substances 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 230000001629 suppression Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 208000001145 Metabolic Syndrome Diseases 0.000 description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 6
- 244000061456 Solanum tuberosum Species 0.000 description 6
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 229950001002 cianidanol Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 6
- 235000019645 odor Nutrition 0.000 description 6
- 235000005875 quercetin Nutrition 0.000 description 6
- 229960001285 quercetin Drugs 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 244000141009 Hypericum perforatum Species 0.000 description 5
- 235000017309 Hypericum perforatum Nutrition 0.000 description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 5
- 210000000636 white adipocyte Anatomy 0.000 description 5
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 4
- UFCLZKMFXSILNL-BKUKFAEQSA-N 3,4-di-O-caffeoylquinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O UFCLZKMFXSILNL-BKUKFAEQSA-N 0.000 description 4
- 208000035985 Body Odor Diseases 0.000 description 4
- 206010006326 Breath odour Diseases 0.000 description 4
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 4
- UFCLZKMFXSILNL-PSEXTPKNSA-N Isochlorogenic acid b Chemical compound O([C@@H]1C[C@@](O)(C[C@H]([C@H]1OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)O)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-PSEXTPKNSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 4
- 206010040904 Skin odour abnormal Diseases 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 238000010908 decantation Methods 0.000 description 4
- 238000002224 dissection Methods 0.000 description 4
- 238000002481 ethanol extraction Methods 0.000 description 4
- 230000002550 fecal effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000002044 hexane fraction Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 231100000299 mutagenicity Toxicity 0.000 description 4
- 230000007886 mutagenicity Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 230000000069 prophylactic effect Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000010907 stover Substances 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 231100000039 Ames test Toxicity 0.000 description 3
- 238000010953 Ames test Methods 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001765 catechin Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- UFCLZKMFXSILNL-BBLPPJRLSA-N (-) 4,5-dicaffeoylquinic acid Natural products OC=1C=C(C=CC=1O)C=CC(=O)O[C@@H]1C[C@@](C[C@H]([C@H]1OC(C=CC1=CC(=C(C=C1)O)O)=O)O)(C(=O)O)O UFCLZKMFXSILNL-BBLPPJRLSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- UFCLZKMFXSILNL-AALYGJCLSA-N 3,4-Dicaffeoylquinic acid Natural products O=C(O[C@@H]1[C@H](OC(=O)/C=C/c2cc(O)c(O)cc2)C[C@](O)(C(=O)O)C[C@@H]1O)/C=C/c1cc(O)c(O)cc1 UFCLZKMFXSILNL-AALYGJCLSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 238000008214 LDL Cholesterol Methods 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UFCLZKMFXSILNL-UHFFFAOYSA-N NSC 649410 Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC1C(O)CC(O)(C(O)=O)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 210000000702 aorta abdominal Anatomy 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229950009125 cynarine Drugs 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 238000007446 glucose tolerance test Methods 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000000713 mesentery Anatomy 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- BWORNNDZQGOKBY-UHFFFAOYSA-N ombuin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(OC)C(O)=C1 BWORNNDZQGOKBY-UHFFFAOYSA-N 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- OAFXTKGAKYAFSI-UHFFFAOYSA-N (3R,5R)-3,4,5-tris{[(2E)-3-(3,4-dihydroxyphenyl)-1-oxoprop-2-en-1-yl]oxy}1-hydroxycyclohexanecarboxylic acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC1C(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC(C(=O)O)(O)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 OAFXTKGAKYAFSI-UHFFFAOYSA-N 0.000 description 1
- OAFXTKGAKYAFSI-JFPZSYFPSA-N (3R,5R)-3,4,5-tris{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1-hydroxycyclohexane-1-carboxylic acid Chemical compound O([C@@H]1CC(C[C@H](C1OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)(O)C(=O)O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 OAFXTKGAKYAFSI-JFPZSYFPSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- VCUVETGKTILCLC-UHFFFAOYSA-N 5,5-dimethyl-1-pyrroline N-oxide Chemical compound CC1(C)CCC=[N+]1[O-] VCUVETGKTILCLC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-GMZLATJGSA-N 5-Caffeoyl quinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-GMZLATJGSA-N 0.000 description 1
- KZBAXKKOXPLOBX-UHFFFAOYSA-N 7,4'-dimethylkaempferol Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(OC)C=C2O1 KZBAXKKOXPLOBX-UHFFFAOYSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102100040038 Amyloid beta precursor like protein 2 Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 150000008151 D-glucosides Chemical class 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 244000299452 Gouania lupuloides Species 0.000 description 1
- 235000000292 Gouania lupuloides Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 101000890401 Homo sapiens Amyloid beta precursor like protein 2 Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001619656 Leucopternis albicollis Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000001940 Massive Hepatic Necrosis Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- CPMVNLYGZUXYIL-UHFFFAOYSA-N Quercetin-3-galactosid Natural products OCC1OC(O)C(O)C(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C1O CPMVNLYGZUXYIL-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000020759 St. John’s wort extract Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 235000018192 pine bark supplement Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 229940106796 pycnogenol Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 108700022737 rat Fat1 Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000013319 spin trapping Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229940099416 st. john's wort extract Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960000340 thiopental sodium Drugs 0.000 description 1
- AWLILQARPMWUHA-UHFFFAOYSA-M thiopental sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC([S-])=NC1=O AWLILQARPMWUHA-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- OAFXTKGAKYAFSI-UPHZGLEOSA-N tricaffeoylquinic acid Natural products OC(=O)[C@@]1(O)C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@H](OC(=O)C=Cc3ccc(O)c(O)c3)[C@@H](C1)OC(=O)C=Cc4ccc(O)c(O)c4 OAFXTKGAKYAFSI-UPHZGLEOSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/105—Sweet potatoes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
Abstract
本発明は、安価な原料から簡易な方法で、抗酸化活性、チロシナーゼ阻害活性、肝保護作用、糖や中性脂肪の吸収抑制作用などの各種生理作用を有するポリフェノール含有抽出物を得ることを目的とする。具体的には、上記課題は、サツマイモ茎葉から得られるポリフェノール含有水溶性サツマイモ茎葉抽出物、その製造方法、上記サツマイモ茎葉抽出物を含有する機能性食品、機能性素材、抗酸化剤、肝保護剤、チロシナーゼ阻害剤、糖吸収抑制剤、中性脂肪吸収抑制剤などによって達成される。An object of the present invention is to obtain a polyphenol-containing extract having various physiological functions such as antioxidant activity, tyrosinase inhibitory activity, hepatoprotective activity, absorption inhibition of sugar and neutral fat, etc. from an inexpensive raw material by a simple method. And Specifically, the above-mentioned problems are solved by a polyphenol-containing water-soluble sweet potato foliage extract obtained from sweet potato foliage, a method for producing the same, a functional food containing the sweet potato foliage extract, a functional material, an antioxidant, and a hepatoprotectant. , A tyrosinase inhibitor, a sugar absorption inhibitor, a neutral fat absorption inhibitor, and the like.
Description
本発明は、ポリフェノールを含有する水溶性サツマイモ茎葉抽出物及びその製造方法に関する。また、本発明は、当該サツマイモ茎葉抽出物を有効成分とする機能性飲食品、機能性素材、医薬品、抗酸化剤、肝保護剤、チロシナーゼ阻害剤、糖吸収抑制剤、中性脂肪吸収抑制剤、肥満の予防・治療剤、抗うつ剤、抗疲労剤、消臭剤、油脂および油脂含有食品の劣化防止剤などにも関する。さらに、本発明は、当該サツマイモ茎葉抽出物を含有する飲食品に関する。 The present invention relates to a water-soluble sweet potato stem-and-leaf extract containing polyphenol and a method for producing the same. The present invention also provides a functional food / beverage product, functional material, pharmaceutical product, antioxidant, hepatoprotectant, tyrosinase inhibitor, sugar absorption inhibitor, neutral fat absorption inhibitor comprising the sweet potato foliage extract as an active ingredient. It also relates to agents for preventing and treating obesity, antidepressants, anti-fatigue agents, deodorants, fats and oils and fat-containing foods. Furthermore, this invention relates to the food / beverage products containing the said sweet potato foliage extract.
ポリフェノール化合物は植物の二次代謝産物として広く植物に含まれており、その種類も多様であることが知られている。これらのポリフェノール化合物は多様な生理活性を持つ点で古くから薬学の分野で研究されており、近年においては食品化学の分野で注目を集めている。
そのなかで、特に最近研究の集中している茶のポリフェノール(カテキン類)においては、抗菌、抗ウィルス、抗酸化、抗突然変異、抗癌、血小板凝集抑制、血圧上昇抑制、血中コレステロール低下、抗う蝕、抗アレルギー、腸内フローラ改善、消臭など非常に広範な生理作用を有することが認知されつつある(特開昭63−214183号、特開平2−6499号、特開平4−178320号、特開2002−326932号)。
一方、サツマイモについては、「シモン芋」といわれるブラジル原産の品種については健康食品として塊根の粉末やその茎葉をお茶にした製品が販売されている。シモン芋葉部の凍結乾燥熱水抽出液のポリフェノール含量と抗酸化活性を調べ、HPLC分析によりポリフェノールの成分としてクロロゲン酸およびカフェ酸を同定した報告がある(日本食品科学工学会誌(2002),49(10),683−687)。
また、ブラジル原産サツマイモ葉に含有される成分について、サツマイモ葉アルコール抽出物からケルセチン−3−グルコシド(quercetin−3−glucoside)、ケンフェロール−4’,7−ジメチルエーテル(kaempferol−4’,7−dimethyl ether)、オムブイン(ombuin)、ケルセチン(quercetin)、ケルセチン−3’,4’,7−トリメチルエーテル(quercetin−3’,4’,7−trimethyl ether)、β−シトステロール(β−sitosterol)および蔗糖(sucrose)の7成分を単離したとの報告がある(Zhongcaoyao(1994),25(4),179−81)。中国産のサツマイモ葉のフラボノイドとして、ケルセチン−3−o−β−D−グルコピラノシル−(6→1)−o−α−L−ラムノピラノシド(quercetin−3−o−β−D−glucopyranosyl−(6→1)−o−α−L−rhamnopyranoside)、ケンフェロール−4,7−ジメチルエーテル(kaempferol−4,7−dimethyl ether)、ケルセチン−3−o−β−D−グルコシド(quercetin−3−o−β−D−glucosideおよびケルセチンをHPLCにより単離したとの報告もある(Journal of Instrumental Analysis(1996),15(1),71−74)。一方、60種のサツマイモについて葉部の凍結乾燥粉末のメタノール抽出液についてHPLC分析によりポリフェノール成分を同定したところ、その主成分はカフェ酸およびその誘導体5種であり、全ての品種で同じ成分が検出されたという報告もある(Journal of Agricultural and Food Chemistry(2002),50,3718−3722)。
機能性については、サツマイモ茎葉の粉砕物が血糖値上昇抑制効果および血圧上昇抑制効果を有するとの報告がある(九州沖縄農業研究センター、[Online]、[平成16年8月4日検索]、インターネット、<URL:
http://konarc.naro.affrc.go.jp/press/20040524/index.html>。また、サツマイモ地上部のエタノール抽出液にαアミラーゼ阻害活性、αグルコシダーゼ阻害活性、ACE阻害活性があるとの報告がある(特開2004−75638号)。Polyphenol compounds are widely contained in plants as plant secondary metabolites, and it is known that their types are diverse. These polyphenol compounds have been studied in the field of pharmacy for a long time because of their various physiological activities, and in recent years, they have attracted attention in the field of food chemistry.
Among them, tea polyphenols (catechins), which have recently been concentrated on research, include antibacterial, antiviral, antioxidant, antimutation, anticancer, platelet aggregation suppression, blood pressure increase suppression, blood cholesterol reduction, It has been recognized that it has a very wide range of physiological effects such as anti-caries, anti-allergy, intestinal flora improvement, deodorization (Japanese Patent Laid-Open Nos. 63-214183, 2-6499, and 4-178320). JP 2002-326932 A).
On the other hand, for sweet potatoes, a Brazilian varieties called "Simon-mochi", products of tuberous root powder and their stems and leaves made into tea are sold as health foods. There is a report that investigated the polyphenol content and antioxidant activity of freeze-dried hot water extract of Simon bud leaves and identified chlorogenic acid and caffeic acid as components of polyphenol by HPLC analysis (Journal of Japan Society for Food Science and Technology (2002), 49 (10), 683-687).
Moreover, about the component contained in the sweet potato leaf native to Brazil, from a sweet potato leaf alcohol extract, quercetin-3-glucoside (quercetin-3-glucoside), kaempferol-4 ', 7-dimethyl ether (kaempferol-4', 7-dimethyl) ether), ombuin, quercetin, quercetin-3 ′, 4 ′, 7-trimethyl ether (quercetin-3 ′, 4 ′, 7-trimethyl ether), β-sitosterol and sucrose There are reports that seven components of (sucrose) have been isolated (Zhongcaoiao (1994), 25 (4), 179-81). As flavonoids of Chinese sweet potato leaves, quercetin-3-o-β-D-glucopyranosyl- (6 → 1) -o-α-L-rhamnopyranoside (quercetin-3-o-β-D-glucopyranosyl- (6 → 1) -o-α-L-rhamnopyranoside), kaempferol-4,7-dimethyl ether, quercetin-3-o-β-D-glucoside (quercetin-3-o-β) -There is also a report that D-glucoside and quercetin were isolated by HPLC (Journal of Instrumental Analysis (1996), 15 (1), 71-74), while the leaf lyophilized powder of 60 kinds of sweet potatoes methanol When the polyphenol component was identified by HPLC analysis of the extract, it was reported that the main component was caffeic acid and five derivatives thereof, and the same component was detected in all varieties (Journal of Agricultural and Food Chemistry (2002). ), 50, 3718-3722).
Regarding the functionality, there is a report that the ground potato crushed material has the effect of suppressing blood glucose level increase and blood pressure increase (Kyushu Okinawa Agricultural Research Center, [Online], [Search August 4, 2004], Internet, <URL:
http: // konarc. naro. affrc. go. jp / press / 200404024 / index. html>. Moreover, it has been reported that the ethanol extract of above-ground sweet potato has α-amylase inhibitory activity, α-glucosidase inhibitory activity, and ACE inhibitory activity (Japanese Patent Laid-Open No. 2004-75638).
現在、栽培されているサツマイモのほとんどが塊根を食用や加工用に利用されている。一方、茎葉についてはごく一部で食用とされているが、ほとんどが未利用な状態である。サツマイモ葉のポリフェノール成分を同定する試みがなされているが、報告されている成分は文献により異なっており、一致した見解は得られていない。また、サツマイモ茎葉から機能性食品素材として適した水溶性抽出物を取得する試みは未だなされていない。
植物に含まれるポリフェノールが広範な生理作用を有することが知られており、茶などの植物から抽出され、機能性食品などに応用されている。機能性食品に適応するためにはその機能性を発揮するための濃度が重要である。機能性を発揮する場合の有効濃度が高くなるとコストが高くなることとは別に、ポリフェノールの味が問題になり食品に用いにくくなる場合がある。ポリフェノールは茶のカテキンのように強い苦味があるものが多いことが知られており、低濃度でも機能性を発揮するものが求められている。また、イチョウ葉エキスや大豆イソフラボンのようにポリフェノールを含むエキスは水に難溶性である場合があるが、飲料等へ添加するためには水溶性の良いものが求められている。
本発明者らはより効率よくしかも経済的にポリフェノール含有抽出物を製造するために種々の原料をスクリーニングし、またポリフェノール含有抽出物の製造方法について検討し、さらにはそのようにして得られたポリフェノール含有抽出物の生理作用等を検討した。その結果、サツマイモの茎葉を原料とし、含水有機溶媒を用いて抽出し水溶性成分を得、ポリフェノール画分を精製することでポリフェノールを高濃度に含有し、かつ水溶性に優れた抽出物を効率よく得ることができることを見出した。また当該抽出物の生理作用を調べたところ予想を大幅に上回る高活性を持っていることを見出し、本発明に到達した。
すなわち、本発明は、下記に示すような、ポリフェノールを含有する水溶性サツマイモ茎葉抽出物、その製造方法、前記サツマイモ茎葉抽出物の用途などを提供する。
(1)サツマイモ茎葉由来の水溶性抽出物であって、ポリフェノール含量が10%以上であることを特徴とするサツマイモ茎葉抽出物。
(2)ポリフェノール含量が20%以上であることを特徴とする、上記(1)記載のサツマイモ茎葉抽出物。
(3)ポリフェノールの成分として少なくともケルセチン−3−グルコシドを含有することを特徴とする、上記(1)または(2)に記載のサツマイモ茎葉抽出物。
(4)ポリフェノール中のケルセチン−3−グルコシド含量が、サツマイモ茎葉抽出物中の1%以上であることを特徴とする、上記(1)ないし(3)のいずれかに記載のサツマイモ茎葉抽出物。
(5)ポリフェノールの成分として少なくともケルセチン−3−グルコシドおよび3,5−ジカフェオイルキナ酸を含有することを特徴とする、上記(1)ないし(4)のいずれかに記載のサツマイモ茎葉抽出物。
(6)サツマイモ茎葉由来の水溶性抽出物であって、ポリフェノール成分として少なくともケルセチン−3−グルコシドおよび3,5−ジカフェオイルキナ酸を含有することを特徴とするサツマイモ茎葉抽出物。
(7)サツマイモ茎葉由来の水溶性抽出物であって、ポリフェノール成分として少なくともケルセチン−3−グルコシド、クロロゲン酸および3,5−ジカフェオイルキナ酸を含有することを特徴とするサツマイモ茎葉抽出物。
(8)サツマイモ茎葉を含水有機溶媒により抽出する工程、前記抽出工程により得られた抽出液より有機溶媒を除去し水画分を得る工程を含んでなることを特徴とするポリフェノールを含有する水溶性のサツマイモ茎葉抽出物の製造方法。
(9)前記工程後にポリフェノールを精製する工程をさらに含む、上記(8)に記載の製造方法。
(10)サツマイモ茎葉の乾燥、粉砕、加熱、焙煎のいずれか一つ、またはこれらを組合わせた工程を前段階として含む、上記(8)または(9)に記載の製造方法。
(11)含水有機溶媒がエタノールであって、含量が40〜90%であることを特徴とする、上記(8)ないし(10)のいずれかに記載の製造方法。
(12)エタノール含量が60%であることを特徴とする、上記(8)ないし(11)のいずれかに記載の製造方法。
(13)上記(8)ないし(12)のいずれかに記載の製造方法により得ることのできるポリフェノールを含有する水溶性のサツマイモ茎葉抽出物。
(14)上記(8)ないし(12)のいずれかに記載の製造方法により得ることのでき、ポリフェノール含量が10%以上であり、かつ当該ポリフェノールの成分として少なくともケルセチン−3−グルコシドを含有することを特徴とする水溶性のサツマイモ茎葉抽出物。
(15)サツマイモ茎葉を水抽出する工程を経て得ることができる水溶性のサツマイモ茎葉抽出物であって、ポリフェノール含量が10%以上であり、当該ポリフェノールの成分として少なくともケルセチン−3−グルコシドを含有することを特徴とする水溶性のサツマイモ茎葉抽出物。
(16)サツマイモの品種が白甘藷に属するものであることを特徴とする、上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)または(15)に記載の水溶性のサツマイモ茎葉抽出物。
(17)サツマイモの品種がシロユタカであることを特徴とする、上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)または(16)に記載の水溶性のサツマイモ茎葉抽出物。
(18)サツマイモ茎葉抽出物の製造工程の前段階に、サツマイモ茎葉の乾燥、粉砕、加熱、焙煎のいずれか一つ、またはこれらを組合わせた工程を含む、上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)または(17)に記載の水溶性のサツマイモ茎葉抽出物。
(19)ポリフェノールを含有する水溶性のサツマイモ茎葉抽出物、または上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)もしくは(18)に記載のサツマイモ茎葉抽出物を有効成分とする機能性飲食品。
(20)抗酸化、肝保護、チロシナーゼ阻害、糖吸収抑制、中性脂肪吸収抑制、肥満の予防・改善、抗うつ、抗疲労、のうちのいずれか1以上の機能を有する(19)に記載の機能性飲食品。
(21)ポリフェノールを含有する水溶性のサツマイモ茎葉抽出物、または上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)もしくは(18)に記載のサツマイモ茎葉抽出物を有効成分とする機能性素材。
(22)ポリフェノールを含有する水溶性のサツマイモ茎葉抽出物、または上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)もしくは(18)に記載のサツマイモ茎葉抽出物を有効成分とする医薬品。
(23)抗酸化、肝保護、チロシナーゼ阻害、糖吸収抑制、中性脂肪吸収抑制、肥満の予防・改善、抗うつ、抗疲労、のうちのいずれか1以上の薬効を有する(22)に記載の医薬品。
(24)ポリフェノールを含有する水溶性のサツマイモ茎葉抽出物、または上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)もしくは(18)に記載のサツマイモ茎葉抽出物を有効成分とする抗酸化剤。
(25)ポリフェノールを含有する水溶性のサツマイモ茎葉抽出物、または上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)もしくは(18)に記載のサツマイモ茎葉抽出物を有効成分とする消臭剤。
(26)ポリフェノールを含有する水溶性のサツマイモ茎葉抽出物、または上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)もしくは(18)に記載のサツマイモ茎葉抽出物を有効成分とする油脂および油脂含有食品の劣化防止剤。
(27)水溶性のサツマイモ茎葉抽出物を、ポリフェノール含量として0.01mg/ml〜30mg/ml含有する飲料水。
(28)上記(1)、(2)、(3)、(4)、(5)、(6)、(7)、(13)、(14)、(15)、(16)、(17)または(18)に記載の水溶性のサツマイモ茎葉抽出物を含有する飲食品。
(29)清涼飲料水、果汁飲料、野菜飲料、豆乳飲料、コーヒー飲料、茶飲料、濃縮飲料、栄養飲料、アルコール飲料、油脂、加工食品、麺パン類、調味料、菓子類(水菓子、ゼリー、ヨーグルト、グミ)、または栄養補助食品である、上記(27)または(28)に記載の飲食品。
本発明によれば、人体に種々の有益な活性を有するポリフェノール含有水溶性サツマイモ茎葉抽出物を提供することができる。本発明の抽出物は、水溶性であるがゆえに、例えば、種々の飲料に溶かして摂取することができるという利点がある。
また、本発明のポリフェノール含有サツマイモ茎葉抽出物の製造方法によれば、特別な材料や施設を用いることなく効率良くポリフェノール含有抽出物を得ることができる。
さらに、本発明のサツマイモ茎葉抽出物は、抗酸化活性、チロシナーゼ阻害活性、肝保護作用、糖や中性脂肪の吸収抑制作用等の活性又は作用を有するので、そのような活性又は作用を有する機能性飲食品、機能性素材、医薬等として有用である。Currently, most of the cultivated sweet potatoes are used for food and processing of tuberous roots. On the other hand, the stems and leaves are only partially edible, but most are unused. Attempts have been made to identify the polyphenol component of sweet potato leaves, but the reported components vary from literature to literature, and there is no consensus. In addition, no attempt has been made to obtain a water-soluble extract suitable as a functional food material from sweet potato stems and leaves.
Polyphenols contained in plants are known to have a wide range of physiological effects, and are extracted from plants such as tea and applied to functional foods. In order to adapt to functional foods, the concentration to exert the functionality is important. In addition to the increase in cost when the effective concentration in the case of exhibiting functionality is increased, the taste of polyphenol may become a problem and may be difficult to use in foods. Polyphenols are known to have many strong bitter tastes like tea catechins, and those that exhibit functionality even at low concentrations are required. In addition, extracts containing polyphenols such as ginkgo biloba extract and soybean isoflavone may be sparingly soluble in water, but those having good water solubility are required for addition to beverages and the like.
In order to produce a polyphenol-containing extract more efficiently and economically, the present inventors screened various raw materials, examined a method for producing a polyphenol-containing extract, and further obtained the polyphenol thus obtained. The physiological action of the contained extract was examined. As a result, we extract sweet potato stems and leaves as raw materials, extract them using a water-containing organic solvent to obtain water-soluble components, and purify the polyphenol fraction to efficiently extract polyphenols at high concentrations and excellent water solubility. I found that I can get well. Moreover, when the physiological effect of the said extract was investigated, it discovered that it had the high activity which exceeded a prediction significantly, and reached | attained this invention.
That is, the present invention provides a water-soluble sweet potato foliage extract containing polyphenol, a method for producing the same, uses of the sweet potato foliage extract, and the like as described below.
(1) A water-soluble extract derived from sweet potato foliage, wherein the polyphenol content is 10% or more.
(2) The sweet potato stem and leaf extract according to (1) above, wherein the polyphenol content is 20% or more.
(3) The sweet potato shoot extract according to (1) or (2) above, which contains at least quercetin-3-glucoside as a component of polyphenol.
(4) The sweet potato foliage extract according to any one of (1) to (3) above, wherein the content of quercetin-3-glucoside in the polyphenol is 1% or more of the sweet potato foliage extract.
(5) The sweet potato shoot extract according to any one of (1) to (4) above, which contains at least quercetin-3-glucoside and 3,5-dicaffeoylquinic acid as components of polyphenol .
(6) A water-soluble extract derived from sweet potato foliage, which contains at least quercetin-3-glucoside and 3,5-dicaffeoylquinic acid as polyphenol components.
(7) A sweet potato foliage extract derived from a sweet potato foliage, which contains at least quercetin-3-glucoside, chlorogenic acid and 3,5-dicaffeoylquinic acid as polyphenol components.
(8) A water-soluble solution containing polyphenol, comprising a step of extracting sweet potato stems and leaves with a water-containing organic solvent, and a step of removing the organic solvent from the extract obtained by the extraction step to obtain a water fraction. Method for producing sweet potato stem and leaf extract.
(9) The production method according to (8), further comprising a step of purifying polyphenol after the step.
(10) The production method according to (8) or (9) above, which comprises, as a previous step, any one of drying, pulverization, heating, roasting of sweet potato foliage, or a combination thereof.
(11) The production method according to any one of (8) to (10) above, wherein the hydrous organic solvent is ethanol and the content is 40 to 90%.
(12) The production method according to any one of (8) to (11) above, wherein the ethanol content is 60%.
(13) A water-soluble sweet potato shoot extract containing polyphenols obtainable by the production method according to any one of (8) to (12) above.
(14) It can be obtained by the production method according to any one of (8) to (12), has a polyphenol content of 10% or more, and contains at least quercetin-3-glucoside as a component of the polyphenol. Water-soluble sweet potato stem and leaf extract characterized by
(15) A water-soluble sweet potato stem and leaf extract obtainable through a step of water-extracting sweet potato stems and leaves, having a polyphenol content of 10% or more and containing at least quercetin-3-glucoside as a component of the polyphenol A water-soluble sweet potato shoot extract characterized by the above.
(16) The above (1), (2), (3), (4), (5), (6), (7), (), wherein the sweet potato variety belongs to white sweet potato 13) The water-soluble sweet potato shoot extract according to (14) or (15).
(17) The above-mentioned (1), (2), (3), (4), (5), (6), (7), (13), ( 14) The water-soluble sweet potato shoot extract according to (15) or (16).
(18) The above (1), (2), comprising a step of any one of drying, pulverization, heating, roasting of sweet potato foliage, or a combination thereof in the previous stage of the production process of the sweet potato foliage extract , (3), (4), (5), (6), (7), (13), (14), (15), (16) or (17) water-soluble sweet potato foliage extract .
(19) Water-soluble sweet potato stem and leaf extract containing polyphenol, or (1), (2), (3), (4), (5), (6), (7), (13), ( 14), (15), (16), (17) or a functional food or drink comprising the sweet potato stem and leaf extract according to (18) as an active ingredient.
(20) It has one or more functions of antioxidant, liver protection, tyrosinase inhibition, sugar absorption inhibition, neutral fat absorption inhibition, obesity prevention / improvement, antidepressant and anti-fatigue. Functional food and drink.
(21) Water-soluble sweet potato stem and leaf extract containing polyphenol, or (1), (2), (3), (4), (5), (6), (7), (13), ( 14), (15), (16), (17) or a functional material comprising the sweet potato stem and leaf extract according to (18) as an active ingredient.
(22) Water-soluble sweet potato stem and leaf extract containing polyphenol, or (1), (2), (3), (4), (5), (6), (7), (13), ( 14), (15), (16), (17) or a pharmaceutical product comprising the sweet potato foliage extract according to (18) as an active ingredient.
(23) Described in (22) having one or more of the following effects: antioxidant, liver protection, tyrosinase inhibition, sugar absorption inhibition, neutral fat absorption inhibition, obesity prevention / improvement, antidepressant, anti-fatigue Pharmaceutical products.
(24) Water-soluble sweet potato stem and leaf extract containing polyphenol, or (1), (2), (3), (4), (5), (6), (7), (13), ( 14), (15), (16), (17) or an antioxidant comprising the sweet potato shoot extract according to (18) as an active ingredient.
(25) Water-soluble sweet potato stem and leaf extract containing polyphenol, or (1), (2), (3), (4), (5), (6), (7), (13), ( 14), (15), (16), (17) or a deodorant comprising the sweet potato stem and leaf extract according to (18) as an active ingredient.
(26) Water-soluble sweet potato stem and leaf extract containing polyphenol, or (1), (2), (3), (4), (5), (6), (7), (13), ( 14), (15), (16), (17) or an oil and fat-containing food deterioration preventive agent comprising the sweet potato shoot extract as an active ingredient.
(27) Drinking water containing 0.01 mg / ml to 30 mg / ml of a water-soluble sweet potato shoot extract as a polyphenol content.
(28) (1), (2), (3), (4), (5), (6), (7), (13), (14), (15), (16), (17) ) Or a food or drink containing the water-soluble sweet potato stem and leaf extract according to (18).
(29) Soft drinks, fruit juice drinks, vegetable drinks, soy milk drinks, coffee drinks, tea drinks, concentrated drinks, nutrition drinks, alcoholic drinks, fats and oils, processed foods, noodle breads, seasonings, confectionery (water confectionery, jelly, The food or drink according to (27) or (28) above, which is a yogurt, gummi) or nutritional supplement.
ADVANTAGE OF THE INVENTION According to this invention, the polyphenol containing water-soluble sweet potato stalk-and-leaf extract which has various beneficial activity for a human body can be provided. Since the extract of the present invention is water-soluble, there is an advantage that it can be ingested after being dissolved in various beverages, for example.
Moreover, according to the method for producing a polyphenol-containing sweet potato foliage extract of the present invention, a polyphenol-containing extract can be efficiently obtained without using special materials or facilities.
Furthermore, the sweet potato foliage extract of the present invention has activities or actions such as antioxidant activity, tyrosinase inhibitory activity, hepatoprotective action, sugar and neutral fat absorption inhibiting action, etc., and thus functions having such activity or action. It is useful as a functional food, drink, functional material, medicine, and the like.
図1は、サツマイモの茎及び葉から得られたサツマイモ茎葉抽出物の液体クロマトグラフィーのチャートである。
図2は、サツマイモの葉から得られたサツマイモ茎葉抽出物の液体クロマトグラフィーのチャートである。
図3は、実施例9のAPPH投与ラット肝障害モデルにおけるサツマイモ茎葉抽出物の抗酸化作用を示すグラフである。(a)は尿中8−OHdGの測定結果を、(b)は肝ホモジナイズ試料中のチオバルビツール酸反応物(TBARS)の測定結果を表す。
図4は、実施例11のラット糖負荷試験におけるサツマイモ茎葉抽出物の糖吸収抑制作用を示すグラフである。
図5は、実施例11の血糖上昇抑制効果についてのグアバ葉抽出物との比較試験の結果を示すグラフである。
図6は、実施例12のラット脂肪負荷試験におけるサツマイモ茎葉抽出物の中性脂肪吸収抑制作用を示すグラフである。
図7は、実施例12の脂肪吸収抑制作用についての緑茶抽出物との比較試験の結果を示すグラフである。
図8は、実施例16のサツマイモ茎葉抽出物の消臭効果を示すグラフである。アンモニア(a)、メルカプタン(b)、トリメチルアミン(c)の結果をそれぞれ表す。
図9は、実施例17の脂肪細胞の状態を示す。
図10は、実施例18の強制遊泳試験におけるマウスのEDBおよびIMOの平均時間を示すグラフである。
図11は、実施例19のサツマイモの茎葉抽出物の濃度における油脂の変敗時間を示すグラフである。FIG. 1 is a liquid chromatography chart of a sweet potato stem and leaf extract obtained from the stem and leaf of sweet potato.
FIG. 2 is a liquid chromatography chart of a sweet potato stem and leaf extract obtained from sweet potato leaves.
FIG. 3 is a graph showing the antioxidant effect of a sweet potato shoot extract in the rat liver injury model administered with APPH in Example 9. (A) shows the measurement result of urinary 8-OHdG, and (b) shows the measurement result of thiobarbituric acid reactant (TBARS) in the liver homogenized sample.
FIG. 4 is a graph showing the sugar absorption inhibitory action of sweet potato stem and leaf extract in the rat sugar tolerance test of Example 11.
FIG. 5 is a graph showing the results of a comparison test with the guava leaf extract on the blood glucose elevation inhibitory effect of Example 11.
6 is a graph showing the neutral fat absorption inhibitory action of sweet potato stem and leaf extract in the rat fat tolerance test of Example 12. FIG.
FIG. 7 is a graph showing the results of a comparative test with the green tea extract for the fat absorption inhibitory effect of Example 12.
FIG. 8 is a graph showing the deodorizing effect of the sweet potato foliage extract of Example 16. The results for ammonia (a), mercaptan (b), and trimethylamine (c) are respectively shown.
FIG. 9 shows the state of fat cells of Example 17.
10 is a graph showing the average time of EDB and IMO of mice in the forced swimming test of Example 18. FIG.
FIG. 11 is a graph showing the deterioration time of fats and oils at the concentration of the stem and leaf extract of sweet potato of Example 19.
以下、本発明を詳細に説明する。
(ポリフェノール含有水溶性サツマイモ茎葉抽出物)
本発明の第1の態様は、サツマイモ茎葉由来の水溶性抽出物であって、ポリフェノールを含有していることを特徴とするサツマイモ茎葉抽出物に関する。本明細書中、「サツマイモ」とは、ヒルガオ科サツマイモ属に属する植物のことをいい、この属であれば如何なる品種のものを用いることもでき、例としてシロユタカ、コガネセンガン、SUKUH、種子島紫、シモンイモ等が挙げられるが、好ましくは白甘藷に属する品種のサツマイモである。白甘藷とは、塊根部の皮がアントシアニンをほとんど含まず、白色であるサツマイモをいう。より好ましくはシロユタカである。なお、本明細書中、「サツマイモ茎葉」は、サツマイモの地上部のうち少なくとも葉を含み、好ましくは茎葉両方を含む材料という意味で用いられる。とりわけ好ましくは葉のみである。サツマイモ茎葉は、通常、用途がなく廃棄処分されているので、このような材料を利用することは資源の再利用の面でも有意義である。ここで用いられるサツマイモ茎葉は、新鮮材料であってもよく、また乾燥材料であってもよい。好ましくは乾燥材料であり、乾燥方法としては天日乾燥、温風乾燥、凍結乾燥等適当な手段を適宜選択し得るが、天日乾燥が好ましい。また、サツマイモ茎葉は、抽出効率を考慮して粉砕したものを使用することもできる。また、サツマイモ茎葉に適宜、焙煎等を施すことにより、抽出物の味や風味を増すことも可能である。本発明のサツマイモ茎葉抽出物は水溶性であるから、例えば、種々の飲料に溶かして摂取することができるという利点がある。ここで、「水溶性」とは、室温で1Lの水に対し、少なくとも100mg以上、好ましくは1g以上、更に好ましくは10g以上、特に好ましくは50g以上溶解できることをいう。
本発明のサツマイモ茎葉抽出物は、有効成分としてサツマイモ茎葉由来のポリフェノールを含有する。本発明のサツマイモ茎葉抽出物は、好ましくはカテキン換算で全不揮発性成分重量の10%以上、好ましくは15%以上、より好ましくは20%以上、さらに好ましくは25%以上、とりわけ好ましくは30%以上のポリフェノールを含有する。ポリフェノール含量の上限は特に限定されないが、本発明のサツマイモ茎葉抽出物は、通常、60%ぐらいまでのポリフェノールを含有する。ポリフェノールの含量は、没食子酸換算による表現を用いてもよい。サツマイモの茎葉由来のポリフェノール成分としては、例えば、ケルセチン−3−グルコシドやケルセチン−3−ガラクトシド等のケルセチン配糖体、クロロゲン酸、3,4−ジカフェオイルキナ酸、3,5−ジカフェオイルキナ酸、4,5−ジカフェオイルキナ酸、3,4,5−トリカフェオイルキナ酸等のカフェ酸誘導体等が例示される。なお、サツマイモの茎葉由来のポリフェノールにおいては、未同定のポリフェノール成分が含有されている可能性があるが、本発明はそのような未同定ポリフェノール成分を排除するものではない。上記ポリフェノール中、ケルセチン−3−グルコシドは体内への吸収が良好なことから好ましいポリフェノール成分である(Olthof MR.ら、J Nutr.2000 May;130(5):1200−1203、Morand C.ら、Free Radic Res.2000 Nov;33(5):667−76.)。ゆえに、本発明の好ましい態様においては、本発明の水溶性サツマイモ抽出物は、水溶性のサツマイモ茎葉抽出物中のポリフェノール成分の構成成分として、少なくともケルセチン−3−グルコシドを有するものであり、さらに好ましくは、ケルセチン−3−グルコシド、3,5−ジカフェオイルキナ酸を含有するものが好ましい。さらに好ましくは、少なくともケルセチン−3−グルコシド、クロロゲン酸および3,5−ジカフェオイルキナ酸を、とりわけ好ましくは、少なくともケルセチン−3−グルコシド、ケルセチン−3ガラクトシド、クロロゲン酸および3,5−ジカフェオイルキナ酸を含有することが望ましい。前記ポリフェノール中のケルセチン−3−グルコシド含量がサツマイモ抽出物中の1%以上、好ましくは2%以上、より好ましくは3%以上、特に好ましくは5%以上であることが望ましい。ケルセチン−3−グルコシド含量の上限は限定されないが、本発明のサツマイモ茎葉抽出物は、通常、前記ポリフェノール中30%ぐらいまでのケルセチン−3−グルコシドを含有する。サツマイモの葉にはケルセチン−3−グルコシド、−ガラクトシドなどのケルセチン配糖体が多く含まれているので、葉の割合が多い原料を用いて抽出するとケルセチン配糖体を多く含んだ画分を得ることができる。なお、ケルセチン−3−ガラクトシドはこれまでサツマイモ茎葉の成分としては知られていなかったものであり、本発明のサツマイモ茎葉抽出物を特徴付ける成分の1つである。前記ポリフェノール中の3,5−ジカフェオイルキナ酸含量は、1%以上が好ましく、より好ましくは2%以上、とりわけ好ましくは3%以上である。クロロゲン酸も含有していることが望ましい。また、本発明のサツマイモ茎葉抽出物は、ポリフェノール以外に例えば、フェニルアラニン、トリプトファン等のアミノ酸、有機酸、多糖類、糖脂質等の副成分が含まれていてもよい。有機酸としては、例えばキナ酸、多糖類としては、例えばオリゴ糖、糖脂質としては、例えばヤラピン等が挙げられ、これらのポリフェノール以外の成分も本発明のサツマイモ茎葉抽出物の好ましい構成成分である。これらのポリフェノール成分または副成分の定量は、例えば、高速液体クロマトグラフィー(HPLC)により行うことができる。
本発明のサツマイモ茎葉抽出物は、製造方法は特に限定されず、抽出効率の観点からは、後述する含水有機溶媒による抽出が好ましいが、水抽出によっても得ることができる。水抽出には、熱水、温水または冷水を用いることができ、目的とする温度の水に、茎葉を入れて一定時間浸漬し、目的成分を抽出する。茎葉は、事前に乾燥および粉砕を施しておくことが好ましい。抽出温度としては例えば、熱水の場合、60〜100℃、好ましくは60〜80℃、温水の場合、30〜60℃、好ましくは50〜60℃、冷水の場合、0〜30℃、好ましくは10〜30℃であるが、抽出効率の点からは熱水抽出が好ましい。抽出時間は特に限定されないが、熱水の場合には10〜150分間、好ましくは20分〜70分間であり、抽出温度を下げるに従い、長時間かけて抽出するのが好ましく、冷水抽出の場合には1日程度かけて抽出することもできる。また、抽出の際には加圧して抽出することができ、特に抽出温度を低くする場合には加圧して抽出するのが望ましい。抽出後には抽出液を冷却して、沈殿を除去し、サツマイモ茎葉抽出物を得ることができる。ドリップ抽出であれば、布や紙のフィルターの上に茎葉を置き、上から熱湯を注いで濾(こ)す。欲する味や風味、香ばしさの違いにあわせて適宜選択できる。さらに、後述する精製過程を付加してもよいが、カラムによる精製を行う前に、抽出液を希釈する工程、もしくは沈殿を除去する際に沈殿除去の促進剤(有機酸、エタノール等)を添加する工程等のカラム精製を実施しやすくするのための工程を加えることが望ましい。得られたサツマイモ茎葉抽出物の水溶液をさらに濃縮して利用してもよいし、乾燥させて水分を除去することにより、粉末状のサツマイモ茎葉抽出物としてもよい。
(サツマイモ茎葉抽出物の製造方法及びその製法によって得ることができる抽出物)
本発明の第2の態様は、サツマイモ茎葉を含水有機溶媒により抽出する工程、前記抽出工程により得られた抽出液より有機溶媒を除去し水画分を得る工程、前記水画分からポリフェノールを精製する工程を含んでなることを特徴とするポリフェノール含有サツマイモ茎葉抽出物の製造方法に関する。本発明の第3の態様はこの製造方法によって得ることができるサツマイモ茎葉抽出物に関する。
以下、本発明の製造方法における各工程の好ましい態様について述べる。
(抽出工程)
まず、本発明の製法においては、サツマイモ茎葉を含水有機溶媒を用いた抽出に供する。ここで用いられるサツマイモ茎葉は、前述の通り、新鮮材料でも乾燥材料であってもよく、抽出効率を考慮すると粉砕したものが好適である。ここで用いられる抽出方法は、特に限定されず、静置又は攪拌条件下、冷浸、温浸または還流するなどの公知の方法を用いることができる。例えば、乾燥させたサツマイモ茎葉を破砕したものに含水有機溶媒を加え、それらを混合し、そのまま浸漬または加熱還流しながら抽出する。加える含水有機溶媒の量は特に限定されないが、乾燥材料を用いる場合は材料の容量の少なくとも3倍以上、新鮮材料を用いる場合は材料の容量の少なくとも5倍以上の容量の含水有機溶媒を加えることが望ましい。
ここで、抽出に用いられる含水有機溶媒としては、サツマイモ茎葉からポリフェノール類を抽出できるものであれば特に限定されず、例えば、水と親水性有機溶媒の混合溶液が用いられる。この混合溶液中の有機溶媒含量は、例えば、40〜90容量%、好ましくは40〜80容量%、より好ましくは50〜80容量%である。親水性有機溶媒としては、例えば、メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、イソブタノール、t−ブタノールなどの一価の低級アルコール;エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、ジプロピレングリコールなどの多価アルコール;メチルセロソルブ、エチルセロソルブなどのセロソルブ類;ジオキサン、テトラヒドロフランなどのエーテル類;アセトン、メチルエチルケトンなどのケトン類などが挙げられる。本発明においては、特に、含水アルコール(エタノール、メタノール等)を好適に用いることができる。本発明者らは、抽出する際の抽出液である含水アルコールについて水分量が多いと抽出されたポリフェノールが時間と共に分解消失していくことを見出している。また、アルコール濃度が高すぎると収量が低下し、匂いや味が悪くなる傾向があるため、適正なアルコール濃度があることを見出した。すなわち、本発明の抽出工程において用いられる含水アルコール(例えば、エタノール)は、好ましくは、40〜90容量%、より好ましくは、50〜80容量%のアルコール(例えば、エタノール)である。特に、60容量%以上のエタノールが望ましい。なお、上記のような抽出は、例えば、10〜70℃、好ましくは40〜60℃で、1時間〜48時間、好ましくは、2時間〜10時間行なわれる。
次いで、上記のようにして得られた抽出液について、有機溶媒を除去し水画分を得る。有機溶媒を除去する方法としては、減圧濃縮による有機溶媒の留去、非親水性有機溶媒(例:ヘキサン等)による有機溶媒の分画など、使用する含水有機溶媒の種類により当業者が用い得る手法を適宜選択し得る。含水エタノールを使用する場合は、減圧濃縮によるアルコールの留去が好ましい。有機溶媒の除去は、溶液中の水の比率が少なくとも70%以上になるまで行うことが好ましい。このようにして得られた有機溶媒を除去した抽出液を水画分と呼ぶこととする。水画分を得る工程で、水に不溶または難溶な成分が沈殿する、または分画されるので、水画分は、水に不溶なサツマイモ茎葉成分が除かれた状態となっている。よって、この工程が、本発明のサツマイモ茎葉抽出物の水溶性を高めるために寄与しているものと考えられる。水に不溶または難溶な成分の沈殿を促すために、水画分を静置したり、数倍量の水を加える操作を行っても良い。沈殿した水に不溶または難溶な成分は、デカントで除く、非親水性有機溶媒(例:ヘキサン等)により分画して除く、ろ過する等適当な手段で除去すればよい。
(精製工程)
次に、上記のようにして得られた水画分のポリフェノールを精製する。ここでポリフェノールを精製するとは、サンプル中の不揮発性成分の総含量におけるポリフェノールの割合を高めることを意味する。具体的には、水画分から、ポリフェノール以外の各種の不揮発性成分を除去することによって精製を達成することができる。最終的に得られるサツマイモ茎葉抽出物(通常、水などの揮発可能な成分を除去した粉末の形態をとる)において、全不揮発性成分中のポリフェノールの含量が10%以上、好ましくは20%以上になればポリフェノール画分が精製されたものとする。精製すなわちポリフェノール以外の不揮発性成分の除去は、吸着剤を用いる方法などの公知の方法が用いられる。例えば、ポリフェノール類を選択的に吸着かつ溶離できる吸着剤を充填したカラムに、上記の水画分を通すことによりポリフェノールを吸着剤に吸着させ、洗浄後、溶出液によって精製ポリフェノールを溶出させる。カラムではなくバッチ法でもよい。また、水画分に対し、エタノール等の親水性有機溶媒を添加し、有機溶媒に難溶性の不揮発性成分(多糖類等)を沈殿させ除去する方法でもよい。このような沈殿除去法と、カラム精製を組み合わせて用いてもよい。
ここで用いられる吸着剤としては、例えば架橋スチレン系の多孔質重合体の合成吸着樹脂、陰イオン交換樹脂、オクタデシル基化学結合型シリカゲル(ODS)等を用いることができる。市販の合成樹脂吸着剤としては、例えば、三菱化成株式会社のダイヤイオンHP−20、HP−21、HP2MG、SP207、SP825、SP850;ローム・アンド・ハース社のアンバーライトXAD−2、XAD−4、XAD−7、XAD−26などを用いることができる。吸着剤を用いる精製方法の実施条件等は当業者に容易に設定できる。市販の吸着剤に、マニュアルが添付されている場合は、そのマニュアルの指示にしたがって吸着操作を行なうことができる。
上記吸着後は、通常、カラムに洗浄液を通すことより不純物などを洗浄・除去する。洗浄液としては、水(好ましくは蒸留水)、1〜10重量%のエタノール水溶液等が好適に用いられる。通常、樹脂量の1〜10倍程度の洗浄液を通液するとよい。洗浄後、溶出液をカラムに通すことによりポリフェノール含有画分を溶出、回収することができる。溶出液としては、例えば、含水アルコール、含水アセトン、含水アセトニトリルなどの含水有機溶媒を用いることができる。特に好適な溶出液は、20%以上のエタノール水溶液または100%エタノールである。通常、溶出液の通液量は樹脂量の2〜6倍程度が望ましい。
このようにして得られたポリフェノール含有画分を減圧濃縮(又は濃縮乾固)することにより有機溶媒を留去させ、サツマイモ茎葉抽出物の水溶液を得ることができる。さらに、サツマイモ茎葉抽出物の水溶液を噴霧乾燥または凍結乾燥などで水分を除去し、粉末状のサツマイモ茎葉抽出物を得ることができる。粉末は、必要に応じて、粉砕器を用いて粒径を揃えたり、微粒粉末とすることもできる。また、デキストリン等の粉末助剤を添加して噴霧乾燥や凍結乾燥を行うことができ、さらに、得られた粉末に安定化剤、賦形剤等を添加することもできる。このようにして得られた組成物、すなわち、液体製剤又は粉末製剤は、後述のサツマイモ茎葉抽出物含有機能性飲食品、機能性素材、医薬製剤、抗酸化剤、肝保護剤、チロシナーゼ阻害剤、糖吸収抑制剤、中性脂肪吸収抑制剤、肥満の予防・治療剤、抗うつ剤、抗疲労剤、消臭剤、油脂および油脂含有食品の劣化防止剤などとして利用できる。
本発明の第3の態様は、上記製造方法によって得ることができるサツマイモ茎葉抽出物である。上記製造方法によって得ることができるサツマイモ茎葉抽出物と物として同一であれば、異なる製造方法によって得られたものであっても本発明のサツマイモ茎葉抽出物に含まれる。物として同一であるかどうかは、例えば、本発明の第1の態様に記載された特徴を有しているかどうかをもって確認することができる。すなわち、上記製造方法によって得ることができるサツマイモ茎葉抽出物の好ましい形態は、上記製造方法によって得ることができ、かつ本発明の第1の態様に記載された水溶性、ポリフェノール含量、ポリフェノール成分、ポリフェノール中の各種成分の含量等で特徴づけられるサツマイモ茎葉抽出物である。
(用途)
本発明の第4の態様は、上記本発明の第1の態様または第3の態様で述べたサツマイモ茎葉抽出物を有効成分とする医薬品、機能性飲食品、機能性素材、抗酸化剤、肝保護剤、チロシナーゼ阻害剤、糖吸収抑制剤、中性脂肪吸収抑制剤、肥満の予防・治療剤、メタボリックシンドロームの予防・治療剤、抗うつ剤、抗疲労剤、消臭剤、油脂および油脂含有食品の劣化防止剤などに関する。さらに、当該サツマイモ茎葉抽出物を含有する飲食品にも関する。ここで用いられるサツマイモ茎葉抽出物の製造方法としては、上記製造方法が好ましいが、特にこれに限定されることはなく、如何なる公知の方法をも用いることができる。ここで用いられるサツマイモ茎葉抽出物の好ましい態様は、本発明の第1の態様または第3の態様に記載された特徴を有しているサツマイモ茎葉抽出物である。
1.抗酸化剤
本発明のサツマイモ茎葉抽出物の抗酸化能は、後述の実施例8の各種の抗酸化能実験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、抗酸化剤の有効成分として用いることができる。
本発明の抗酸化剤は、実施例9のラットを用いた実験によって、生体内においても活性酸素を消去する作用を有することが確認されている。したがって、本発明の抗酸化剤は、活性酸素が関与する種々の疾患や症状の予防または治療に用いることができる。活性酸素が関与する疾患としては、活性酸素によって誘導され得る癌、アレルギー、動脈硬化など過酸化脂質が関与する疾患などが挙げられる。活性酸素が関与する症状としては、老化にともなう各種症状、シミ、シワ、肌荒れなどが挙げられる。
2.肝保護剤
本発明のサツマイモ茎葉抽出物の肝保護作用は、後述の実施例9のラットを用いた実験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、肝保護剤の有効成分として用いることができる。
本発明の肝保護剤は、肝臓機能の不全又は低下が関与する疾患や症状の予防または治療および改善に用いることができる。そのような肝臓機能の不全又は低下が関与する疾患としては、例えば、肝硬変、ウイルス肝炎、劇症肝炎、肝癌等の肝疾患、肝臓の損傷・疲弊などが挙げられる。肝臓機能の不全又は低下が関与する症状として、二日酔い、アルコール肝炎、倦怠感、疲労感、血行不良などが挙げられる。これらの疾患や症状を予防するためには、本発明の肝保護剤を事前または平時から摂取することにより肝臓機能を向上させておくことが好ましい。
3.チロシナーゼ阻害剤
本発明のサツマイモ茎葉抽出物がチロシナーゼ阻害活性を有することは、後述の実施例10に記載のチロシナーゼ阻害活性試験によって確認されている。チロシナーゼはポリフェノールオキシダーゼともいわれ、ポリフェノールを不活性化し、皮膚のメラニン生成や食品の褐変反応を増悪する酵素である。したがって、本発明のサツマイモ茎葉抽出物は、チロシナーゼ阻害剤の有効成分として用いることができる。
本発明のチロシナーゼ阻害剤は、チロシナーゼが関与する疾患や症状の予防または治療および改善に用いることができる。そのようなチロシナーゼが関与する症状としては、例えば、皮膚のメラニンの発生、日焼け、色素沈着などが挙げられる。また、本発明のチロシナーゼ阻害剤を摂取することにより、皮膚のメラニンの発生を抑制することができ、美白効果が期待できる。したがって、本発明のサツマイモ茎葉抽出物は、美白作用を有する化粧品又は機能性食品の有効成分としても用いることもできる。
4.糖吸収抑制剤
本発明のサツマイモ茎葉抽出物が糖吸収抑制作用を有することは、後述の実施例11に記載のラットを用いた実験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、糖吸収抑制剤の有効成分として用いることができる。
本発明の糖吸収抑制剤は、糖吸収を抑制し、血糖値の上昇を抑制する作用があるので、人体中に摂取される糖が関与する疾患や症状の予防または治療および改善に用いることができる。そのような糖が関与する疾患としては、例えば、糖尿病、肥満、糖尿病性合併症などが挙げられる。また、本発明のサツマイモ茎葉抽出物は、食後の過血糖を防ぐ効果があるため血糖値が気になる人に対し訴求力のある機能性食品素材になり得る。
5.中性脂肪吸収抑制剤
本発明のサツマイモ茎葉抽出物が中性脂肪吸収抑制作用及び吸収遅延作用を有することは、実施例12に記載のラットを用いた実験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、中性脂肪吸収抑制剤の有効成分として利用できる。
本発明の中性脂肪吸収抑制剤は、中性脂肪吸収を抑制する作用を有するので、中性脂肪の過多が関与する疾患や症状の予防または治療および改善に用いることができる。そのような疾患としては、例えば、高コレステロール症、高脂血症、虚血性心疾患、脳血管障害などが挙げられる。また、本発明のサツマイモ茎葉抽出物は、体脂肪が気になる人に対し訴求力のある機能性食品素材となり得る。
6.肥満の予防・治療剤
本発明のサツマイモ茎葉抽出物が脂肪細胞の分化および肥大化抑制作用を有することは、実施例17に記載のin vitroにおけるラット腸間膜由来白色脂肪細胞の分化および肥大化抑制試験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、脂肪細胞の分化および肥大化抑制剤の有効成分として利用でき、ゆえに、肥満の予防・治療剤として用いることができる。さらに、サツマイモ茎葉抽出物は、上記の糖吸収抑制作用、中性脂肪吸収抑制作用も有することから、これら作用の相乗効果によっても肥満の予防・治療効果が期待できる。
本発明の肥満の予防・治療剤は、肥満が関与する疾患や症状の予防または治療および改善に用いることができる。そのような疾患としては、例えば動脈硬化、高血圧、糖尿病などが挙げられる。また、本発明のサツマイモ茎葉抽出物は、肥満および体脂肪が気になる人に対し訴求力のある機能性食品素材となり得る。
7.メタボリックシンドロームの予防・治療剤
本発明のサツマイモ茎葉抽出物は、上記のとおり糖吸収抑制作用によって高血糖症状を予防・改善し、中性脂肪吸収抑制作用によって、高脂血症、とりわけ高トリグリセライド血症の予防・改善が可能となり、脂肪細胞の分化および肥大化抑制作用等により肥満の予防・治療作用等を有することも併せてメタボリックシンドロームの予防・治療剤の有効成分として利用できる。メタボリックシンドロームとは、主に内臓脂肪の蓄積に起因し、肥満、糖尿病、高脂血症、高血圧等の複数の危険因子が重積し、動脈硬化や冠動脈疾患(最終イベントとして、心筋梗塞や脳梗塞)の発症リスクが高まった病態をいう。食習慣の乱れから様々な生活習慣病が発症しがちな現代社会において、問題視されている疾患のひとつである。本発明のサツマイモ茎葉抽出物は、メタボリックシンドロームの予防・改善に有効な作用を複数併せ持つことから、メタボリックシンドロームが気になる人に対し訴求力のある機能性食品素材となり得る。
8.抗うつ剤
本発明のサツマイモ茎葉抽出物が抗うつ作用を有することは、実施例18に記載のマウス強制水泳法による抗うつ作用の検討によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、抗うつ剤の有効成分として利用できる。また、ストレスを軽減し、リラックス効果も期待できる。
本発明の抗うつ剤は、抗うつ作用を有するので、うつ病およびうつ病に関連する症状の予防または治療および改善に用いることができる。また、本発明のサツマイモ茎葉抽出物は、うつ病が気になる人、ストレスの多い現代人に対し訴求力のある機能性食品素材となり得る。
9.抗疲労剤
本発明のサツマイモ茎葉抽出物が抗疲労作用を有することは、実施例18に記載のマウス強制水泳法による抗疲労作用の検討によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、抗疲労剤の有効成分として利用できる。
例えば長時間の運動による肉体的な疲労を軽減する、また、気分をリラックスさせて精神的なストレスや疲労を感じにくくする等、身体的および精神的な疲労の予防、軽減、改善が期待である。本発明のサツマイモ茎葉抽出物は、例えば常に身体的な疲労を受けるスポーツ選手、長時間の労働などによって身体的および精神的疲労を感じやすい人に対し訴求力のある機能性食品素材となり得る。
10.消臭剤
本発明のサツマイモ茎葉抽出物がヒトやペットの口臭、体臭、便臭等の原因物質に対する脱臭効果を有することは、実施例16に記載の試験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、消臭剤の有効成分として利用できる。
サツマイモ茎葉抽出物は、ヒトやペットの口臭、体臭、便臭に対する消臭、飲食品の消臭等にも使用することができ、脱臭効果を有する物質の中でも、極めて幅広い応用範囲で使用可能な物質となり得る。
11.油脂および油脂含有食品の劣化防止剤
本発明のサツマイモ茎葉抽出物が油脂および油脂含有食品の劣化防止に有効であることは、実施例19に記載の油脂安定性試験によって確認されている。したがって、本発明のサツマイモ茎葉抽出物は、油脂の変敗を抑制する劣化防止剤として、とりわけ動物性の油脂の劣化防止剤として有用である。豚脂・ラードなどの動物脂質を使用する加工食品(フライドポテトやスナック、カップ麺等)をはじめ、その他様々な油脂類に添加し、油脂の劣化防止に応用できる。食品油脂の劣化防止には、粉末状のサツマイモ茎葉抽出物を油脂中にぱらぱらと添加したり、サツマイモ茎葉抽出物の水溶液を油脂に混ぜて乳化したりすることも可能である。また、粉末状のサツマイモ茎葉抽出物を天ぷら粉、パン粉、小麦粉等の揚げ衣に添加したり、油脂で加工する食品原料中に混合したりすることにより、食品を油脂で調理すると同時に油脂の劣化を防止することもできる。食品油脂への添加量は特に限定されないが、好ましくは10ppm以上、より好ましくは200ppm以上、とりわけ好ましくは500ppm以上であり、上限は限定されないが、サツマイモ茎葉抽出物をソフトカプセルに加工し、油脂の50重量%程度のサツマイモ茎葉抽出物を添加することも可能である。
12.医薬品、機能性飲食品および機能性素材
本発明のサツマイモ茎葉抽出物は抗酸化活性、肝保護作用、チロシナーゼ阻害活性、糖や中性脂肪の吸収抑制作用等の活性又は作用を有し、機能性素材として優れた機能を有している。よって本発明のサツマイモ茎葉抽出物は機能性素材の有効成分として利用できる。
機能性素材は、機能性を有する材料、原料として、あらゆる用途に利用できる。形態も特に限定されず、有効成分はサツマイモ茎葉抽出物のみであってもよいし、その他の機能性素材や原料と混合された状態であってもよく、粉末、液体、成形体等あらゆる形をとり得る。実施例20で、サツマイモ茎葉抽出物を原料として、顆粒、錠剤およびグミを作製し、機能性素材として利用しやすいことは確認されている。
機能性素材として食品用途で効果が期待できる1日あたりの摂取量は成人1日あたり0.1mg/kg以上、好ましくは1mg/kg以上、更に好ましくは10mg/kg以上、特に好ましくは30mg/kg以上である。1日あたりの摂取量の上限は特に限定されないが、例えば、2000mg/kg程度までは許容範囲内である。但し、好ましい摂取量の範囲は、製品形態や個人の特性により当然変動することが考えられる。
機能性素材としては、食品として摂取する以外の用途として、抗酸化効果を有することから食品の酸化防止剤、食品色素の安定剤、消臭剤等への利用が考えられる。また、チロシナーゼ阻害活性を有することから化粧料としての利用が考えられる。化粧料は、常法に従って製造することができる。化粧料は、一般の皮膚化粧料に限定されるものではなく、医薬部外品、指定医薬部外品、外用医薬品等を包含するものであり、その剤型も目的に応じて任意に選択することができる。すなわち、クリーム、軟膏、乳液、溶液、ゲル等の剤型やパック、ローション、パウダー、スティック等の形態とすることができる。抽出物の配合量は、化粧料の総量を基準として、成分固形分換算で0.0001〜1.0%が好ましく、特に好ましくは0.001〜0.1%である。
本発明のサツマイモ茎葉抽出物を有効成分とする機能性飲食品は、本発明のサツマイモ茎葉抽出物を適当な製剤に製剤化すること、または飲食品に添加することにより提供される。本発明のサツマイモ茎葉抽出物を有効成分とする医薬品は、本発明のサツマイモ茎葉抽出物を適当な製剤に製剤化することで提供される。
医薬品または機能性飲食品(健康食品)としての製剤の形態としては、粉末剤、顆粒剤、カプセル剤、丸剤、錠剤等の固形製剤、水剤、懸濁剤、乳剤等の液剤等の経口投与剤が挙げられる。この経口投与剤は、経口投与剤の形態に応じて一般に用いられる賦形剤、崩壊剤、結合剤、滑沢剤、界面活性剤、アルコール類、水、水溶性高分子、甘味料、矯味剤、酸味料等を添加して製造することができる。サツマイモ茎葉抽出物は、経口投与用剤中に、用途及び形態によっても異なるが、一般に0.1〜100重量%、特に1〜80重量%含有するのが好ましい。
また、医薬品として本発明のサツマイモ茎葉抽出物を投与する場合、その投与量はその作用、対象疾患、投与対象、投与ルートなどにより変化するが、例えば、一般的に体重60kgの成人においては、ポリフェノール含量として1日につき約1mg〜2000mg、好ましくは約10mg〜500mg、より好ましくは30mg〜300mgである。
サツマイモ茎葉抽出物を飲食品に添加することにより機能性飲食品を提供する場合には、食品や飲料等にサツマイモ茎葉抽出物をその機能性を発揮できるように添加する。本発明のサツマイモ茎葉抽出物は、食事中の糖質や中性脂肪の過剰吸収および肝臓での過酸化脂質の産生を抑制できる特性を有しカロリーダイエットにも有望であることから、糖質を多く含む製品(果汁、ジュース、ビール、酒類、チョコレート、クッキー、はちみつ製品、飴、ガム、ゼリー、アイスクリーム、ヨーグルト、和菓子・洋菓子類)、中性脂肪を多く含む原料(魚油、マーガリン、乳製品、バター、卵黄油、マヨネーズ、サラダ油、ドレッシング)を利用した加工食品、過酸化脂質を多く発生する揚げ物製品(天ぷら、ポテトチップス等のスナック菓子、揚げせんべい、インスタント麺)等、および糖質・中性脂肪の吸収低下や体脂肪の減少を促す成分(緑茶・桑葉茶、グアバ、明日葉、大豆蛋白・豆乳、キチン・キトサン、アルギン酸、オリゴ糖・デキストリン・食物繊維)を利用した機能性強化向け製品に混合すると効果的である。さらに、うこん、異性化リノール酸、セサミン、ビタミンE、CoQ10、αリポ酸、カルニチン、アミノ酸(バリン、ロイシン、イソロイシン、アルギニン、テアニン、ヒスチジン)、人参類(エゾウコギ、紅参、西洋人参)、有機酸類(ビタミンC、酢、クエン酸)、ビタミンB群、すっぽん、蟻、プラセンタ、トウガラシ、黒胡椒、カロチノイド類(リコピン、アスタキサンチン、ルテイン)、イソフラボン、キノコ、海藻由来多糖類(アガリクス、フコイダン)、各種ハーブ類(イチョウ葉、松樹皮、ブドウ抽出物)、ベリー類(ブルーベリー)、脂質類(EPA、DHA)から選ばれる物質を組み合わせた栄養補助食品も効果的である。食品や飲料等への添加量としては、サツマイモ茎葉抽出物の1日あたりの摂取量が成人1日あたり1mg/kg以上、好ましくは30mg/kg以上となるように含有させることが好ましい。1日あたりの摂取量の上限は特に限定されないが、例えば、2000mg/kg程度までは許容範囲内である。但し、好ましい摂取量の範囲は、製品形態や個人の特性により当然変動することが考えられる。
13.飲食品
本発明の水溶性サツマイモ茎葉抽出物を、ポリフェノール含量として0.001mg/ml〜30mg/ml、好ましくは0.01mg/ml〜30mg/ml、より好ましくは0.01mg/ml〜10mg/ml、最も好ましくは0.01mg/ml〜3mg/ml含有する飲食品として用いることができる。本発明により、サツマイモ茎葉抽出物中のポリフェノール含量を高めることが可能となり、ゆえに高濃度にサツマイモ茎葉由来のポリフェノールを含有する飲料水とすることができる。嗜好性の面では、ポリフェノール含量として約3mg/ml以下であることが望ましく、また、サツマイモ茎葉抽出物の薬効・機能を発揮させるためには、約0.01mg/ml以上含有するのが効率的である。これらの点から、より好ましくは0.05mg/ml〜2.5mg/ml、さらに好ましくは0.1mg/ml〜2.5mg/ml、とりわけ好ましくは0.3mg/ml〜2mg/mlであるが、加工する飲食品の種類に応じて適宜増減することができる。また、サツマイモ茎葉抽出物の水溶液をゼリーなどの菓子類に加工したり、サツマイモ茎葉抽出物の粉末を麺類、インスタント食品等の加工食品に混ぜ込んだり、さらに栄養補助食品の素材とすることもできる。飲食品としては、清涼飲料水、果汁飲料、野菜飲料、豆乳飲料、コーヒー飲料、茶飲料、濃縮飲料、栄養飲料、アルコール飲料、油脂、加工食品、麺パン類、調味料、菓子類(水菓子、ゼリー、ヨーグルト、グミ)、栄養補助食品、等をあげることができる。1回あたりのサツマイモ茎葉由来のポリフェノール摂取量は、約1mg〜2000mg、好ましくは約5mg〜500mg、より好ましくは約10mg〜300mgに調製されていることが好ましい。Hereinafter, the present invention will be described in detail.
(Polyphenol-containing water-soluble sweet potato stem and leaf extract)
The 1st aspect of this invention is a water-soluble extract derived from a sweet potato foliage, Comprising: It is related with the sweet potato foliage extract characterized by including polyphenol. In the present specification, “sweet potato” refers to a plant belonging to the genus Sweet potato of the convolvulaceae family, and any variety can be used as long as it belongs to this genus, such as white yutaka, koganesengan, SUKUH, purple tanegashima, potato potato Among them, the sweet potato of the variety belonging to white sweet potato is preferable. White sweet potato refers to sweet potatoes whose white root skin is almost free of anthocyanins and is white. More preferred is Shiroyutaka. In the present specification, “sweet potato foliage” is used to mean a material containing at least leaves, preferably both foliage, of the above-ground part of sweet potato. Especially preferred are leaves only. Since sweet potato foliage is usually discarded for no use, the use of such materials is also significant in terms of resource reuse. The sweet potato foliage used here may be a fresh material or a dry material. A dry material is preferred, and as a drying method, suitable means such as sun drying, hot air drying, freeze drying and the like can be selected as appropriate, but sun drying is preferable. The sweet potato stems and leaves can be crushed in consideration of extraction efficiency. It is also possible to increase the taste and flavor of the extract by appropriately roasting the sweet potato stems and leaves. Since the sweet potato stem and leaf extract of the present invention is water-soluble, there is an advantage that it can be taken and dissolved in various beverages, for example. Here, “water-soluble” means that at least 100 mg, preferably 1 g, more preferably 10 g, particularly preferably 50 g or more can be dissolved in 1 L of water at room temperature.
The sweet potato foliage extract of the present invention contains a polyphenol derived from sweet potato foliage as an active ingredient. The sweet potato stem and leaf extract of the present invention is preferably 10% or more, preferably 15% or more, more preferably 20% or more, still more preferably 25% or more, particularly preferably 30% or more of the total nonvolatile component weight in terms of catechin. Of polyphenols. The upper limit of the polyphenol content is not particularly limited, but the sweet potato shoot extract of the present invention usually contains up to about 60% polyphenol. The polyphenol content may be expressed in terms of gallic acid. Examples of the polyphenol component derived from the stem and leaves of sweet potato include quercetin glycosides such as quercetin-3-glucoside and quercetin-3-galactoside, chlorogenic acid, 3,4-dicaffeoylquinic acid, and 3,5-dicaffeoyl Examples thereof include caffeic acid derivatives such as quinic acid, 4,5-dicaffeoylquinic acid, and 3,4,5-tricaffeoylquinic acid. In addition, in the polyphenol derived from the stem and leaves of sweet potato, an unidentified polyphenol component may be contained, but the present invention does not exclude such an unidentified polyphenol component. Among the polyphenols, quercetin-3-glucoside is a preferable polyphenol component because of its good absorption into the body (Oltof MR. Et al., J Nutr. 2000 May; 130 (5): 1200-1203, Morand C. et al., Free Radical Res. 2000 Nov; 33 (5): 667-76.). Therefore, in a preferred embodiment of the present invention, the water-soluble sweet potato extract of the present invention has at least quercetin-3-glucoside as a constituent component of the polyphenol component in the water-soluble sweet potato stem and leaf extract, and more preferably Are preferably those containing quercetin-3-glucoside and 3,5-dicaffeoylquinic acid. More preferably at least quercetin-3-glucoside, chlorogenic acid and 3,5-dicaffeoylquinic acid, particularly preferably at least quercetin-3-glucoside, quercetin-3 galactoside, chlorogenic acid and 3,5-dicaffeic acid It is desirable to contain oil quinic acid. It is desirable that the content of quercetin-3-glucoside in the polyphenol is 1% or more, preferably 2% or more, more preferably 3% or more, particularly preferably 5% or more in the sweet potato extract. The upper limit of the quercetin-3-glucoside content is not limited, but the sweet potato shoot extract of the present invention usually contains up to about 30% quercetin-3-glucoside in the polyphenol. Sweet potato leaves contain a lot of quercetin glycosides such as quercetin-3-glucoside and -galactoside, so if you extract using a raw material with a high percentage of leaves, you get a fraction that contains a lot of quercetin glycosides be able to. Quercetin-3-galactoside has been heretofore unknown as a component of sweet potato foliage and is one of the components that characterize the sweet potato foliage extract of the present invention. The content of 3,5-dicaffeoylquinic acid in the polyphenol is preferably 1% or more, more preferably 2% or more, and particularly preferably 3% or more. It is also desirable to contain chlorogenic acid. Moreover, the sweet potato shoot extract of this invention may contain subcomponents, such as amino acids, such as phenylalanine and a tryptophan, organic acids, polysaccharides, and glycolipids other than polyphenol. Examples of organic acids include quinic acid, polysaccharides include, for example, oligosaccharides, and glycolipids include, for example, yarapine. Components other than these polyphenols are also preferable constituents of the sweet potato stem and leaf extract of the present invention. . Quantification of these polyphenol components or subcomponents can be performed, for example, by high performance liquid chromatography (HPLC).
The production method of the sweet potato foliage extract of the present invention is not particularly limited. From the viewpoint of extraction efficiency, extraction with a water-containing organic solvent described later is preferable, but it can also be obtained by water extraction. Hot water, hot water, or cold water can be used for water extraction, and the target components are extracted by putting the foliage in water at a target temperature and immersing it for a certain period of time. The foliage is preferably dried and crushed in advance. As extraction temperature, for example, in the case of hot water, 60-100 ° C, preferably 60-80 ° C, in the case of hot water, 30-60 ° C, preferably 50-60 ° C, in the case of cold water, 0-30 ° C, preferably Although it is 10-30 degreeC, the hot water extraction is preferable from the point of extraction efficiency. The extraction time is not particularly limited, but in the case of hot water, it is 10 to 150 minutes, preferably 20 minutes to 70 minutes. It is preferable to extract over a long time as the extraction temperature is lowered. Can also be extracted over a day. Further, the extraction can be performed under pressure during extraction, and it is desirable to perform the extraction under pressure particularly when the extraction temperature is lowered. After extraction, the extract can be cooled to remove the precipitate and obtain a sweet potato shoot extract. For drip extraction, place the foliage on a cloth or paper filter, pour hot water from above, and filter. It can be selected as appropriate according to the desired taste, flavor and aroma. In addition, the purification process described later may be added, but before the purification by the column, a step of diluting the extract, or an accelerator for removing the precipitate (organic acid, ethanol, etc.) is added when removing the precipitate. It is desirable to add a process for facilitating column purification, such as a process of performing the process. The obtained aqueous solution of sweet potato foliage extract may be further concentrated and used, or may be dried to remove water to obtain a powdery sweet potato foliage extract.
(Production method of sweet potato stem and leaf extract and extract obtainable by the production method)
The second aspect of the present invention includes a step of extracting sweet potato stems and leaves with a water-containing organic solvent, a step of removing the organic solvent from the extract obtained by the extraction step to obtain a water fraction, and purifying polyphenol from the water fraction. The present invention relates to a method for producing a polyphenol-containing sweet potato shoot extract characterized by comprising a step. The third aspect of the present invention relates to a sweet potato foliage extract obtainable by this production method.
Hereinafter, preferred embodiments of the respective steps in the production method of the present invention will be described.
(Extraction process)
First, in the production method of the present invention, sweet potato foliage is subjected to extraction using a water-containing organic solvent. As described above, the sweet potato foliage used here may be a fresh material or a dry material, and is preferably pulverized in consideration of extraction efficiency. The extraction method used here is not particularly limited, and a known method such as cooling, digestion or refluxing can be used under standing or stirring conditions. For example, a water-containing organic solvent is added to a crushed dried sweet potato foliage, they are mixed, and extracted while being immersed or heated under reflux. The amount of the water-containing organic solvent to be added is not particularly limited, but when using a dry material, add a water-containing organic solvent having a capacity of at least 3 times the volume of the material, and when using a fresh material, a volume of at least 5 times the volume of the material. Is desirable.
Here, the water-containing organic solvent used for extraction is not particularly limited as long as it can extract polyphenols from sweet potato stalks and leaves. For example, a mixed solution of water and a hydrophilic organic solvent is used. The organic solvent content in the mixed solution is, for example, 40 to 90% by volume, preferably 40 to 80% by volume, and more preferably 50 to 80% by volume. Examples of the hydrophilic organic solvent include monovalent lower alcohols such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol, and t-butanol; ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, and the like. Polyhydric alcohols; cellosolves such as methyl cellosolve and ethyl cellosolve; ethers such as dioxane and tetrahydrofuran; ketones such as acetone and methyl ethyl ketone. In the present invention, water-containing alcohols (ethanol, methanol, etc.) can be particularly preferably used. The present inventors have found that the extracted polyphenols decompose and disappear with time when the water content of the hydrous alcohol that is the extract at the time of extraction is large. In addition, when the alcohol concentration is too high, the yield decreases, and the smell and taste tend to deteriorate. That is, the hydrous alcohol (for example, ethanol) used in the extraction step of the present invention is preferably 40 to 90% by volume, more preferably 50 to 80% by volume of alcohol (for example, ethanol). In particular, 60% by volume or more of ethanol is desirable. The extraction as described above is performed, for example, at 10 to 70 ° C., preferably 40 to 60 ° C., for 1 hour to 48 hours, preferably 2 hours to 10 hours.
Next, the organic solvent is removed from the extract obtained as described above to obtain a water fraction. The method for removing the organic solvent can be used by those skilled in the art depending on the type of hydrous organic solvent used, such as distillation of the organic solvent by concentration under reduced pressure, fractionation of the organic solvent with a non-hydrophilic organic solvent (eg, hexane, etc.). The method can be selected as appropriate. When hydrous ethanol is used, the alcohol is preferably distilled off by concentration under reduced pressure. The removal of the organic solvent is preferably performed until the ratio of water in the solution is at least 70%. The extract obtained by removing the organic solvent thus obtained will be referred to as a water fraction. In the step of obtaining the water fraction, components that are insoluble or hardly soluble in water are precipitated or fractionated, so that the water fraction is in a state where sweet potato stem and leaf components that are insoluble in water are removed. Therefore, it is considered that this step contributes to increase the water solubility of the sweet potato shoot extract of the present invention. In order to promote precipitation of components that are insoluble or hardly soluble in water, the water fraction may be allowed to stand or an operation of adding several times the amount of water may be performed. The precipitated water-insoluble or hardly soluble component may be removed by an appropriate means such as removal by decantation, fractionation by non-hydrophilic organic solvent (eg, hexane etc.), filtration.
(Purification process)
Next, the polyphenol of the water fraction obtained as described above is purified. Purifying polyphenol here means increasing the proportion of polyphenol in the total content of non-volatile components in the sample. Specifically, purification can be achieved by removing various nonvolatile components other than polyphenols from the water fraction. In the finally obtained sweet potato stem and leaf extract (usually in the form of a powder from which volatile components such as water have been removed), the content of polyphenols in all non-volatile components is 10% or more, preferably 20% or more. If so, the polyphenol fraction shall be purified. For purification, that is, removal of non-volatile components other than polyphenol, a known method such as a method using an adsorbent is used. For example, polyphenol is adsorbed on the adsorbent by passing the above water fraction through a column packed with an adsorbent capable of selectively adsorbing and eluting polyphenols, and purified polyphenol is eluted with an eluent after washing. A batch method may be used instead of the column. Alternatively, a method may be used in which a hydrophilic organic solvent such as ethanol is added to the water fraction to precipitate and remove non-volatile components (such as polysaccharides) that are hardly soluble in the organic solvent. A combination of such precipitation removal method and column purification may be used.
As the adsorbent used here, for example, a synthetic adsorption resin of a crosslinked styrene-based porous polymer, an anion exchange resin, octadecyl group chemically bonded silica gel (ODS), or the like can be used. Examples of commercially available synthetic resin adsorbents include, for example, Diaion HP-20, HP-21, HP2MG, SP207, SP825, SP850 from Mitsubishi Kasei Corporation; Amberlite XAD-2, XAD-4 from Rohm and Haas XAD-7, XAD-26, and the like can be used. Conditions for carrying out the purification method using the adsorbent can be easily set by those skilled in the art. When a manual is attached to a commercially available adsorbent, the adsorption operation can be performed according to the instructions of the manual.
After the adsorption, impurities and the like are usually washed and removed by passing a washing solution through the column. As the cleaning liquid, water (preferably distilled water), 1 to 10% by weight ethanol aqueous solution, or the like is suitably used. Usually, it is better to pass a cleaning solution of about 1 to 10 times the amount of resin. After washing, the polyphenol-containing fraction can be eluted and collected by passing the eluate through a column. As the eluent, for example, a water-containing organic solvent such as water-containing alcohol, water-containing acetone, water-containing acetonitrile or the like can be used. A particularly suitable eluent is 20% or more of an aqueous ethanol solution or 100% ethanol. Usually, the flow rate of the eluate is preferably about 2 to 6 times the amount of resin.
The polyphenol-containing fraction thus obtained is concentrated under reduced pressure (or concentrated to dryness) to distill off the organic solvent, whereby an aqueous solution of sweet potato stem and leaf extract can be obtained. Further, the water content of the aqueous solution of the sweet potato shoots and leaves extract is removed by spray drying or freeze drying to obtain a powdered sweet potato shoots and leaves extract. If necessary, the powder may have a uniform particle size using a pulverizer or may be a fine powder. Further, powder auxiliary agents such as dextrin can be added for spray drying or freeze drying, and stabilizers, excipients, and the like can be added to the obtained powder. The composition thus obtained, that is, a liquid preparation or a powder preparation, contains a sweet potato foliage extract-containing functional food and drink, a functional material, a pharmaceutical preparation, an antioxidant, a hepatoprotectant, a tyrosinase inhibitor, It can be used as a sugar absorption inhibitor, a neutral fat absorption inhibitor, a prophylactic / therapeutic agent for obesity, an antidepressant, an anti-fatigue agent, a deodorant, an oil and fat, and a food containing fat and oil.
The third aspect of the present invention is a sweet potato foliage extract obtainable by the above production method. If it is the same as a sweet potato foliage extract obtained by the said manufacturing method, even if it is obtained by a different manufacturing method, it is contained in the sweet potato foliage extract of this invention. Whether or not they are the same can be confirmed by, for example, whether or not they have the characteristics described in the first aspect of the present invention. That is, a preferred form of the sweet potato shoot extract obtainable by the above production method is the water solubility, polyphenol content, polyphenol component, polyphenol which can be obtained by the above production method and described in the first aspect of the present invention. It is a sweet potato stem and leaf extract characterized by the content of various components in it.
(Use)
According to a fourth aspect of the present invention, there is provided a pharmaceutical, a functional food / beverage product, a functional material, an antioxidant, a liver comprising the sweet potato foliage extract described in the first aspect or the third aspect of the present invention as an active ingredient. Contains protective agent, tyrosinase inhibitor, sugar absorption inhibitor, neutral fat absorption inhibitor, prevention / treatment agent for obesity, prevention / treatment agent for metabolic syndrome, antidepressant, anti-fatigue agent, deodorant, fats and oils It relates to food deterioration inhibitors. Furthermore, it is related with the food / beverage products containing the said sweet potato stem and leaf extract. As the method for producing the sweet potato foliage extract used here, the above production method is preferable, but the method is not particularly limited, and any known method can be used. A preferred embodiment of the sweet potato foliage extract used here is a sweet potato foliage extract having the characteristics described in the first aspect or the third aspect of the present invention.
1. Antioxidant
The antioxidant ability of the sweet potato shoot extract of the present invention has been confirmed by various antioxidant ability experiments in Example 8 described later. Therefore, the sweet potato shoot extract of this invention can be used as an active ingredient of an antioxidant.
It has been confirmed that the antioxidant of the present invention has an action of eliminating active oxygen even in vivo by an experiment using the rat of Example 9. Therefore, the antioxidant of the present invention can be used for the prevention or treatment of various diseases and symptoms involving active oxygen. Diseases involving active oxygen include diseases that involve lipid peroxides such as cancer, allergy, and arteriosclerosis that can be induced by active oxygen. Symptoms involving active oxygen include various symptoms associated with aging, spots, wrinkles, rough skin, and the like.
2. Hepatoprotectant
The hepatoprotective action of the sweet potato foliage extract of the present invention has been confirmed by experiments using rats of Example 9 described later. Therefore, the sweet potato foliage extract of the present invention can be used as an active ingredient of a hepatoprotectant.
The hepatoprotective agent of the present invention can be used for the prevention or treatment and amelioration of diseases and symptoms associated with insufficiency or decline in liver function. Examples of such a disease associated with liver function failure or reduction include liver cirrhosis, viral hepatitis, fulminant hepatitis, liver cancer such as liver cancer, liver damage and exhaustion, and the like. Symptoms related to liver function failure or decline include hangover, alcoholic hepatitis, malaise, fatigue, poor circulation, and the like. In order to prevent these diseases and symptoms, it is preferable to improve the liver function by ingesting the hepatoprotective agent of the present invention in advance or during normal times.
3. Tyrosinase inhibitor
It has been confirmed by the tyrosinase inhibitory activity test described in Example 10 below that the sweet potato shoot extract of the present invention has tyrosinase inhibitory activity. Tyrosinase, also called polyphenol oxidase, is an enzyme that inactivates polyphenols and exacerbates skin melanogenesis and food browning. Therefore, the sweet potato shoot extract of the present invention can be used as an active ingredient of a tyrosinase inhibitor.
The tyrosinase inhibitor of the present invention can be used for the prevention or treatment and amelioration of diseases and symptoms involving tyrosinase. Examples of symptoms involving such tyrosinase include skin melanin generation, sunburn, and pigmentation. Moreover, by ingesting the tyrosinase inhibitor of the present invention, the generation of melanin in the skin can be suppressed, and a whitening effect can be expected. Therefore, the sweet potato foliage extract of the present invention can also be used as an active ingredient in cosmetics or functional foods having a whitening effect.
4). Sugar absorption inhibitor
It has been confirmed by experiments using rats described in Example 11 described later that the sweet potato extract of the present invention has a sugar absorption inhibitory action. Therefore, the sweet potato foliage extract of the present invention can be used as an active ingredient of a sugar absorption inhibitor.
Since the sugar absorption inhibitor of the present invention has the action of suppressing sugar absorption and suppressing an increase in blood sugar level, it can be used for the prevention or treatment and improvement of diseases and symptoms related to sugar ingested in the human body. it can. Examples of such diseases involving sugars include diabetes, obesity, diabetic complications, and the like. Moreover, since the sweet potato foliage extract of this invention has the effect which prevents the hyperglycemia after a meal, it can become a functional food material with appeal to the person who is worried about a blood glucose level.
5. Neutral fat absorption inhibitor
It has been confirmed by experiments using rats described in Example 12 that the sweet potato stem and leaf extract of the present invention has a neutral fat absorption inhibitory action and an absorption delay action. Therefore, the sweet potato shoot extract of this invention can be utilized as an active ingredient of a neutral fat absorption inhibitor.
Since the neutral fat absorption inhibitor of the present invention has an action of suppressing neutral fat absorption, it can be used for the prevention or treatment and improvement of diseases and symptoms associated with an excess of neutral fat. Examples of such diseases include hypercholesterolemia, hyperlipidemia, ischemic heart disease, cerebrovascular disorder and the like. Moreover, the sweet potato foliage extract of this invention can become a functional food material with appeal to the person worried about body fat.
6). Obesity prevention / treatment agent
The sweet potato foliage extract of the present invention has an adipocyte differentiation and hypertrophy inhibitory effect, as confirmed by the in vitro rat mesentery-derived white adipocyte differentiation and hypertrophy suppression test described in Example 17. Yes. Therefore, the sweet potato foliage extract of the present invention can be used as an active ingredient of an adipocyte differentiation and hypertrophy inhibitor, and therefore can be used as a prophylactic / therapeutic agent for obesity. Furthermore, since the sweet potato stem and leaf extract also has the above-described sugar absorption inhibitory action and neutral fat absorption inhibitory action, the synergistic effect of these actions can be expected to prevent and treat obesity.
The prophylactic / therapeutic agent for obesity of the present invention can be used for the prevention or treatment and improvement of diseases and symptoms associated with obesity. Examples of such diseases include arteriosclerosis, hypertension and diabetes. Moreover, the sweet potato foliage extract of this invention can become a functional food material appealing to the person worried about obesity and body fat.
7). Prevention and treatment of metabolic syndrome
As described above, the sweet potato stem and leaf extract of the present invention can prevent and ameliorate hyperglycemia symptoms by suppressing sugar absorption, and can prevent and ameliorate hyperlipidemia, especially hypertriglycerideemia, by suppressing neutral fat absorption. Thus, it can also be used as an active ingredient of a preventive / therapeutic agent for metabolic syndrome because it has an action for preventing / treating obesity due to an action of inhibiting adipocyte differentiation and hypertrophy. Metabolic syndrome is mainly due to the accumulation of visceral fat, and multiple risk factors such as obesity, diabetes, hyperlipidemia, and hypertension accumulate, resulting in arteriosclerosis and coronary artery disease (final events such as myocardial infarction and brain It refers to a condition that increases the risk of developing (infarction). This is one of the diseases that are regarded as a problem in modern society where various lifestyle-related diseases tend to develop due to disturbance of eating habits. Since the sweet potato stem and leaf extract of the present invention has a plurality of actions effective for preventing and improving metabolic syndrome, it can be a functional food material appealing to those who are concerned about metabolic syndrome.
8). Antidepressant
It has been confirmed by examination of the antidepressant action by the mouse forced swimming method described in Example 18 that the sweet potato foliage extract of the present invention has an antidepressant action. Therefore, the sweet potato shoot extract of this invention can be utilized as an active ingredient of an antidepressant. It also reduces stress and can be expected to relax.
Since the antidepressant of the present invention has an antidepressant action, it can be used for prevention or treatment and amelioration of depression and symptoms associated with depression. In addition, the sweet potato shoot extract of the present invention can be a functional food material that has appealing power for people who are concerned about depression and modern people with much stress.
9. Anti-fatigue
It has been confirmed by the examination of the anti-fatigue action by the mouse forced swimming method described in Example 18 that the sweet potato stem and leaf extract of the present invention has an anti-fatigue action. Therefore, the sweet potato shoot extract of this invention can be utilized as an active ingredient of an anti-fatigue agent.
For example, it is expected to prevent, reduce, and improve physical and mental fatigue, such as reducing physical fatigue caused by prolonged exercise, and relaxing mood to make it difficult to feel mental stress and fatigue. . The sweet potato foliage extract of the present invention can be a functional food material that appeals to athletes who are constantly subject to physical fatigue, and those who are likely to feel physical and mental fatigue due to long working hours.
10. Deodorants
It has been confirmed by the test described in Example 16 that the sweet potato stem and leaf extract of the present invention has a deodorizing effect on causative substances such as bad breath, body odor, and fecal odor of humans and pets. Therefore, the sweet potato foliage extract of the present invention can be used as an active ingredient of a deodorant.
Sweet potato stem and leaf extract can be used for deodorizing human and pet bad breath, body odor, fecal odor, food and drink, etc., and it can be used in a very wide range of applications among deodorizing substances. Can be a substance.
11. Deterioration preventive agent for oils and fats and oil-containing foods
It has been confirmed by the oil and fat stability test described in Example 19 that the sweet potato foliage extract of the present invention is effective in preventing the deterioration of oils and fats and oil-containing foods. Therefore, the sweet potato foliage extract of the present invention is useful as a deterioration preventing agent that suppresses the deterioration of fats and oils, and particularly as a deterioration preventing agent for animal fats and oils. It can be added to various types of fats and oils, including processed foods (fried potatoes, snacks, cup noodles, etc.) that use animal lipids such as pork fat and lard, and can be applied to prevent the deterioration of fats and oils. In order to prevent the deterioration of food fats and oils, it is possible to add powdery sweet potato stem and leaf extract to the fats and oils, or to mix and emulsify an aqueous solution of the sweet potato stem and leaf extract into the fats and oils. In addition, by adding powdered sweet potato foliage extract to deep-fried clothing such as tempura flour, bread crumbs, flour, etc., or mixing it into food ingredients processed with fats and oils, the food is cooked with fats and oils and fats deteriorate. Can also be prevented. The amount added to the food fat is not particularly limited, but is preferably 10 ppm or more, more preferably 200 ppm or more, and particularly preferably 500 ppm or more. The upper limit is not limited, but the sweet potato stem and leaf extract is processed into soft capsules, and 50 It is also possible to add a sweet potato stover extract of about% by weight.
12 Pharmaceuticals, functional foods and drinks and functional materials
The sweet potato foliage extract of the present invention has activities or actions such as antioxidant activity, hepatoprotective action, tyrosinase inhibitory activity, sugar and neutral fat absorption inhibitory action, etc., and has an excellent function as a functional material. . Therefore, the sweet potato shoot extract of this invention can be utilized as an active ingredient of a functional material.
The functional material can be used for various purposes as a functional material and raw material. The form is not particularly limited, and the active ingredient may be only the sweet potato stem and leaf extract, or may be in a state mixed with other functional materials and raw materials. It can take. In Example 20, it was confirmed that granules, tablets and gummi were produced from sweet potato foliage extract as a raw material, and were easy to use as a functional material.
Daily intake that is expected to be effective in food applications as a functional material is 0.1 mg / kg or more per day for an adult, preferably 1 mg / kg or more, more preferably 10 mg / kg or more, and particularly preferably 30 mg / kg. That's it. Although the upper limit of the daily intake is not particularly limited, for example, it is within an allowable range up to about 2000 mg / kg. However, the range of preferable intake may naturally vary depending on the product form and individual characteristics.
As a functional material, it can be used for food antioxidants, food pigment stabilizers, deodorants and the like because it has an antioxidant effect as a use other than ingestion as food. Moreover, since it has tyrosinase inhibitory activity, utilization as cosmetics can be considered. The cosmetic can be produced according to a conventional method. Cosmetics are not limited to general skin cosmetics, but include quasi-drugs, designated quasi-drugs, external medicines, etc., and the dosage form is arbitrarily selected according to the purpose. be able to. That is, dosage forms such as creams, ointments, emulsions, solutions, gels, and forms such as packs, lotions, powders, and sticks can be used. The blending amount of the extract is preferably 0.0001 to 1.0%, particularly preferably 0.001 to 0.1% in terms of component solid content, based on the total amount of the cosmetic.
The functional food or drink comprising the sweet potato foliage extract of the present invention as an active ingredient is provided by formulating the sweet potato foliage extract of the present invention into an appropriate formulation or adding it to the food or drink. The pharmaceutical which uses the sweet potato foliage extract of this invention as an active ingredient is provided by formulating the sweet potato foliage extract of this invention in a suitable formulation.
Oral forms such as powders, granules, capsules, pills, tablets and other solid preparations, liquids such as liquids, suspensions and emulsions, etc. An administration agent is mentioned. This orally-administered agent is an excipient, disintegrant, binder, lubricant, surfactant, alcohol, water, water-soluble polymer, sweetener, flavoring agent generally used depending on the form of the orally-administered agent. In addition, it can be produced by adding a sour agent or the like. The sweet potato shoot extract varies depending on the use and form in the preparation for oral administration, but is generally contained in an amount of 0.1 to 100% by weight, particularly 1 to 80% by weight.
In addition, when the sweet potato foliage extract of the present invention is administered as a pharmaceutical, its dosage varies depending on its action, target disease, administration subject, administration route, etc. For example, in an adult generally weighing 60 kg, The content is about 1 mg to 2000 mg per day, preferably about 10 mg to 500 mg, more preferably 30 mg to 300 mg.
When a functional food or drink is provided by adding a sweet potato foliage extract to a food or drink, the sweet potato foliage extract is added to food or beverage so as to exhibit its functionality. The sweet potato foliage extract of the present invention has the property of suppressing excessive absorption of carbohydrates and neutral fat in the diet and production of lipid peroxide in the liver, and is also promising for a calorie diet. Products containing a lot (fruit juice, juice, beer, alcoholic beverages, chocolate, cookies, honey products, strawberries, gum, jelly, ice cream, yogurt, Japanese confectionery / Western confectionery), raw materials rich in neutral fat (fish oil, margarine, dairy products) Processed foods using butter, egg yolk oil, mayonnaise, salad oil, dressing), fried food products that generate a large amount of lipid peroxide (tempura, potato chips and other snacks, fried rice crackers, instant noodles), and sugar / neutral Ingredients that reduce fat absorption and decrease body fat (green tea, mulberry leaf tea, guava, tomorrow, soy protein, soy milk, chitin, chitosan, a Gin acid, it is effective to mix the oligosaccharide-dextrin dietary fiber) functionality enhancement for products using. Furthermore, umami, isomerized linoleic acid, sesamin, vitamin E, CoQ10, alpha lipoic acid, carnitine, amino acids (valine, leucine, isoleucine, arginine, theanine, histidine), ginseng (Ezocogi, Red ginseng, Western ginseng), organic Acids (vitamin C, vinegar, citric acid), vitamin B group, sardine, ants, placenta, pepper, black pepper, carotenoids (lycopene, astaxanthin, lutein), isoflavones, mushrooms, seaweed-derived polysaccharides (Agaricus, fucoidan), Nutritional supplements that combine substances selected from various herbs (ginkgo leaves, pine bark, grape extract), berries (blueberries), and lipids (EPA, DHA) are also effective. As an addition amount to foods, beverages, etc., it is preferable to contain so that the daily intake of the sweet potato stem and leaf extract is 1 mg / kg or more, preferably 30 mg / kg or more per adult day. Although the upper limit of the daily intake is not particularly limited, for example, it is within an allowable range up to about 2000 mg / kg. However, the range of preferable intake may naturally vary depending on the product form and individual characteristics.
13. Food and drink
The water-soluble sweet potato foliage extract of the present invention has a polyphenol content of 0.001 mg / ml to 30 mg / ml, preferably 0.01 mg / ml to 30 mg / ml, more preferably 0.01 mg / ml to 10 mg / ml, most Preferably, it can be used as a food or drink containing 0.01 mg / ml to 3 mg / ml. According to the present invention, it is possible to increase the polyphenol content in the sweet potato stem and leaf extract, and therefore, it is possible to obtain a drinking water containing polyphenols derived from sweet potato stem and leaf at a high concentration. In terms of palatability, the polyphenol content is desirably about 3 mg / ml or less, and in order to exert the medicinal effects / functions of the sweet potato stem and leaf extract, it is efficient to contain about 0.01 mg / ml or more. It is. From these points, more preferably 0.05 mg / ml to 2.5 mg / ml, still more preferably 0.1 mg / ml to 2.5 mg / ml, and particularly preferably 0.3 mg / ml to 2 mg / ml. The amount can be appropriately increased or decreased depending on the type of food or drink to be processed. In addition, the sweet potato stem and leaf extract aqueous solution can be processed into jelly and other sweets, the sweet potato stem and leaf extract powder can be mixed with processed foods such as noodles and instant foods, and can be used as a dietary supplement. . Food and drink products include soft drinks, fruit juice drinks, vegetable drinks, soy milk drinks, coffee drinks, tea drinks, concentrated drinks, nutrition drinks, alcoholic drinks, fats and oils, processed foods, noodle breads, seasonings, confectionery (water confectionery, Jelly, yogurt, gummi), dietary supplements, and the like. It is preferable that the amount of polyphenol derived from sweet potato foliage per time is adjusted to about 1 mg to 2000 mg, preferably about 5 mg to 500 mg, more preferably about 10 mg to 300 mg.
次に、本発明を実施例に基づいて更に詳細に説明するが、本発明はこれらの実施例に限定されるものではない。
実施例1 サツマイモ茎葉抽出物の抽出条件の検討
サツマイモ茎葉抽出物の製造にあたり、エタノール濃度によってポリフェノールの抽出効率がどのように変化するか調べた。サツマイモの品種としてシロユタカを用い、栽培4ヶ月のものの茎葉を収穫し、天日にて乾燥させたものを破砕し抽出に用いた。抽出精製操作は下記に示した手法に従った。
(1)条件検討として1つの抽出条件に乾燥、粉砕したサツマイモ茎葉90gを用いた。
(2)抽出の条件設定として、エタノール濃度(0%(水)、20%、40%、60%、80%)を変えた5条件で検討した。
(3)抽出は初回700mlの抽出液で室温12時間放置することで抽出を行い、その後、濾過を行い、その濾液を捕集するとともに抽出残渣に500mlの抽出液を加え、抽出を12時間行った。その後同じ操作を行い、計3回の抽出を行い、捕集した抽出液を合せた。
(4)抽出液をロータリーエバポレーターで200ml程度まで濃縮し、その後、50mlのヘキサンで分画し、水層部分を捕集した。
(5)三菱化学から販売されているDIAION HP20を用いて精製を行った。50gのDIAION HP20を水に置換したカラム作り、捕集した水層部分をカラムに通した。その後、カラム容量の約500mlの水で洗浄した後、約250mlの90%エタノールでポリフェノール画分を溶出させ、捕集した。
(6)捕集したポリフェノール画分はポリフェノール量を測定するとともに濃縮乾固させ、重量を測定した。
捕集したポリフェノール画分は東洋紡エンジニアリング株式会社から販売されているポリフェノール測定器(PA−20)を用いて、カテキン換算としてポリフェノール量を測定した。
次に抽出液中のポリフェノールの安定性を調べた。安定性については抽出直後のポリフェノール濃度と12日間室内に放置した後のポリフェノール濃度を比較し濃度の低下率を安定性の指標とした。結果を表2に示す。
実施例2 ポリフェノールの純度向上法の検討
機能性食品において機能性成分の純度を、コストをかけずに上げることは重要なことである。例えば不純物の中に渋みなど、好ましくない成分が含まれている場合があり、純度を上げることにより、相対的に好ましくない成分を少なくできるからである。そこで、サツマイモの茎と葉に分けて抽出を実施し、さらに濃縮後、時間とともに発生する沈殿を除去する方法を検討した。検討条件として、下記の項目で検討した。
(a)サツマイモの茎を分離し、60%エタノールを用いた実施例1の手法でポリフェノール画分を得、その画分の乾固重量あたりのポリフェノール量つまり純度を調べた。ただし、実施例1のヘキサン分画は省略した。
(b)サツマイモの葉を分離し、60%エタノールを用いた実施例1の手法でポリフェノール画分を得、その画分の乾固重量あたりのポリフェノール量つまり純度を調べた。ただし、実施例1のヘキサン分画は(a)と同様省略した。
(c)サツマイモの葉を分離し、60%エタノールを用いた実施例1の方法で抽出し、200mlの濃縮液を得、その濃縮液を3日間静置した後、3日間で生成した沈殿を除去したものをHP−20カラムに通し実施例1と同じようにポリフェノール画分を捕集した。そして、その画分の乾固重量あたりのポリフェノール量つまり純度を調べた。ただし、実施例1のヘキサン分画は(a)と同様省略した。
(d)サツマイモの葉を分離し、60%エタノールを用いた実施例1の方法で抽出し、200mlの濃縮液を得、その濃縮液に約4倍容量のエタノールを加え3日放置した。3日間で生成した沈殿を除去した後、再びロータリーエバポレーターでエタノールを除去した後、HP−20カラムに通し実施例1と同じようにポリフェノール画分を捕集した。そして、その画分の乾固重量あたりのポリフェノール量つまり純度を調べた。ただし、実施例1のヘキサン分画は(a)と同様省略した。
その結果を表3に示す。
実施例3 液体クロマトグラフィーによる成分の検索
60%エタノールを用いた実施例1の手法でサツマイモ茎葉もしくは葉より抽出分画したポリフェノール画分(サツマイモ茎葉抽出物)を液体クロマトグラフィーで成分を検索した。条件を下に示す。
条件:カラム: Shima−pack VP−ODS(島津製)
カラム温度: 40℃
溶離液: A液4.5mMクエン酸水:アセトニトリル:イソプロパノール
100:10:3
B液6mMクエン酸水:アセトニトリル:イソプロパノール
100:47:3
溶離液勾配: 時間 A/B
0min 85/15
40min 0/100(リニアグラジェント)
50min 0/100
60min 85/15(リニアグラジェント)
図1にサツマイモ茎葉から60%エタノールを用いて実施例1の方法で得たサツマイモ茎葉抽出物の液体クロマトグラフィーのチャートを示した。ピークの解析から、当該抽出物には、ケルセチン−3−グルコシド、ケルセチン−3−ガラクトシド、クロロゲン酸および3種のジカフェオイルキナ酸(3,4−ジカフェオイルキナ酸、3,5−ジカフェオイルキナ酸、4,5−ジカフェオイルキナ酸)が含まれていることが分かった。また、図2にはサツマイモ葉から60%エタノールを用いて実施例1の方法で得たサツマイモ茎葉抽出物の液体クロマトグラフィーのチャートを示した。葉のみを用いた抽出物においては特にケルセチン−3−グルコシドやケルセチン−3−ガラクシドが多く含まれていることが分かった。
実施例4 80%エタノールを用いたサツマイモ茎葉抽出物の製造
以下の手法でサツマイモ茎葉抽出物を製造した。
(1)サツマイモの乾燥茎葉2.22kgを20Lの抽出器に入れ、80%のエタノールを13.2L加え加温抽出(75℃)を2時間行い、ヌッチェにより濾過し、抽出液を約10L得た。
(2)さらに同様な操作を3度行い。抽出液40Lを得た。抽出液を減圧下約1/7まで濃縮した。
(3)ヘキサン8.0L加え脂溶性成分を分離した後、ヘキサン層を除去した。
(4)水層部分は、減圧下さらに溶液が約5L程度になるまで溶媒を留去した。
(5)濃縮溶液に水を5L加えた。希釈溶液に不純物が下層にたまったため、デカンテーションにより不溶物を除去した。
(6)上澄み液を吸着樹脂(HP20)3Lに通液した後、水4Lにて樹脂を洗浄した。
(7)樹脂から90%エタノール10Lを用いて吸着物を溶離させた。
(8)溶出液は減圧下溶媒を留去乾固させ、噴霧乾燥機により粉末サンプル54.43g(収率2.45%)得た。
得られた粉末サンプル(サツマイモ茎葉抽出物)のポリフェノール含量はカテキン換算で約34%、ポリフェノール中のケルセチン−3−グルコシド含量は5.6%であった。また、液体クロマトグラフィーにて実施例3と同様にケルセチン−3−グルコシド、ケルセチン−3−ガラクトシド、クロロゲン酸およびジカフェオイルキナ酸が含まれていることを確認した。
実施例5 60%エタノールを用いたサツマイモ茎葉抽出物の製造
乾燥サツマイモ茎葉1.5kgを粉砕し、6.1Lの60%エタノールを添加し2時間以上抽出を行い、1次抽出液を搾汁し3.5Lを回収した。1次搾汁液と同量の60%エタノールを添加し、12時間以上置いた後、2次抽出液を搾汁し3.34Lを回収した。1次抽出液と2次抽出液を合わせてロータリーエバポレーターで約1/3量(2.3L)に減圧濃縮した。壁面に付着した油性成分はデカントで除去し、得られた水溶液に2倍量の100%エタノールを添加し、12時間以上放置した。沈殿物(多糖類等と思われる)をデカントで除去し、上澄みをロータリーエバポレーターで約1/7量(990ml)に減圧濃縮した。得られた水溶液をDIAION HP20(三菱化学)カラムに通した。カラム容量の5倍量の水で洗浄した後、カラム容量の2倍量の90%エタノールで溶出し、溶出液をスプレードライヤーで乾固し、サツマイモ茎葉抽出物を得た。乾燥茎葉からの抽出物収率は0.66%、抽出物中のポリフェノール含量は41.3%、ポリフェノール中のケルセチン−3−グルコシド含量は3.0%であった。また、液体クロマトグラフィーにて実施例3と同様にケルセチン−3−グルコシド、ケルセチン−3−ガラクトシド、クロロゲン酸およびジカフェオイルキナ酸が含まれていることを確認した。
実施例6 抽出方法の比較
60%エタノール抽出、熱水抽出、水抽出についてケルセチン−3−グルコシド抽出量の比較を行った。
(1)60%エタノール抽出
乾燥サツマイモ茎葉を60%エタノールで抽出し、ロータリーエバポレーターで濃縮後HP20カラムにかけ、90%エタノールで溶出した画分を乾固し、ケルセチン−3−グルコシド抽出量を測定した。
(2)熱水抽出およびエタノール沈殿
乾燥サツマイモ茎葉を90℃の熱水で抽出し、2倍量の100%エタノールを添加後、生じた沈殿を除去し、ロータリーエバポレーターで濃縮後HP20カラムにかけ、90%エタノールで溶出した画分を乾固し、ケルセチン−3−グルコシド抽出量を測定した。
(3)熱水抽出
乾燥サツマイモ茎葉を90℃の熱水で抽出し、ロータリーエバポレーターで濃縮後HP20カラムにかけ、90%エタノールで溶出した画分を乾固し、ケルセチン−3−グルコシド抽出量を測定した。
(4)水抽出
乾燥サツマイモ茎葉を水で抽出し、2倍量の100%エタノールを添加後、生じた沈殿を除去し、ロータリーエバポレーターで濃縮後HP20カラムにかけ、90%エタノールで溶出した画分を乾固し、ケルセチン−3−グルコシド抽出量を測定した。結果を表4に示す。
熱水抽出によって、大量にエタノールに不溶な成分が抽出される。この物質は、カラム精製過程で、90%エタノールによって溶出する際に不溶化すると考えられ、カラムを水で洗浄したにもかかわらず、90%エタノールでの溶出の際に、強固に樹脂に結合して、褐色の色が抜けなくなる。これはカラムの再生に影響すると予想された。ついで、熱水抽出液や水抽出液に2倍量の100%エタノールを加え、67%のエタノール濃度にすると、もやもやとした粘着性のある沈殿物が多量に析出した。この沈殿物をろ過した後にカラム精製を実施するとカラムへの色素沈着は観察されなかった。しかしながら、熱水抽出および水抽出にカラム精製過程を加えた製法は、ケルセチン−3−グルコシド抽出量は60%エタノール抽出に劣り、また、結局エタノールを使用せねばならず、工程削減の効果も得られないので60%エタノール抽出と比較して、抽出効率の点からは優位性は低いと判断される。
実施例7 各種サツマイモ品種の茎葉成分の比較
実施例1ないし6で使用したサツマイモ品種シロユタカと、コガネセンガン、SUKUH、種子島紫およびシモンイモの4品種について茎葉に含まれるポリフェノール成分の比較を行った。シロユタカ、コガネセンガン、SUKUH、種子島紫は乾燥サツマイモ茎葉を60%エタノールで抽出しろ過したサンプルをHPLC分析に供した。シモンイモについては市販のお茶(茎葉を使用したお茶)を60%エタノールで抽出しろ過したサンプルをHPLC分析に供した。
その結果、シロユタカと他の4品種においてクロマトグラフィーで検出される成分の種類に大きな差はなく、含有される物質の種類は同等であると考えられたが、各成分の含有割合は、品種によって若干異なっている。また、シロユタカ葉のみを用いたサツマイモ葉抽出物は、他の品種の抽出物と比較して、ケルセチン−3−グルコシドを多く含み、望ましいことが分かった。
実施例8 抗酸化能の確認
サツマイモ茎葉抽出物を用いて抗酸化能を測定した。
(1)スーパーオキシド消去活性
実施例4で得たサツマイモ茎葉抽出物のスーパーオキシド消去活性を電子スピン反応(ESR)法で測定した。結果は3.9×104単位/g(J.Biol.Chem.,244,6049(1969)に定義された単位)となりサツマイモポリフェノールに抗酸化能があることが確認できた。抗酸化能としては高いレベルであるものの、抗酸化能が非常に高いと言われるピクノジェノール(1.6×105単位/g)と比べると4分の1程度であった。
(2)DPPHラジカル消去能
実施例4で得たサツマイモ茎葉抽出物および実施例2で得た茎のみの抽出物または葉のみの抽出物についてDHHPラジカル消去能を電子スピン反応(ESR)法で測定した。実施例4で得たサツマイモ茎葉抽出物は653μmol/g、実施例2で得た茎のみの抽出物は304μmol/g、実施例2で得た葉のみの抽出物は1273μmol/gであった(活性は、サンプル1gあたりのトロロックスμmol相当量で表示)。市販のお茶粉末では515μmol/g程度と言われており、サツマイモ茎葉抽出物はお茶粉末と同等かそれよりも優れた活性を示した。
(3)ヒドロキシラジカル消去能
実施例4で得たサツマイモ茎葉抽出物および実施例2で得た茎のみの抽出物または葉のみの抽出物について、過酸化水素−2価鉄イオン系にて発生させたヒドロキシラジカルの消去能をDMPOを用いたスピントラッピング法で測定した。実施例4で得たサツマイモ茎葉抽出物は10.8mmol/g、実施例2で得た茎のみの抽出物は16.8mmol/g、実施例2で得た葉のみの抽出物は14.4mmol/gであった(活性は、サンプル1gあたりのマンニトールmmol相当量で表示)。市販のお茶粉末では9.3mmol/g程度と言われており、サツマイモ茎葉抽出物はお茶粉末と同等かそれよりも優れた活性を示した。
実施例9 サツマイモ茎葉抽出物の肝保護作用
サツマイモ茎葉抽出物を食品や飲料で摂取した際に、成分が腸管から吸収され血液に移行し、実際に体内でフリーラジカルを消去できるかどうかについて確認した。サツマイモ茎葉抽出物を投与したラットと非投与のラットを用いてラジカルイニシエーターである2,2’−アゾビスアミジノプロパン二塩酸塩(AAPH)を腹腔に投与し、その影響を調べた。試験の材料と方法を下記に示す。
(a)供試動物
種:ラット、系統:SD、性別:オス、入荷時週齢:6週齢
(b)試験群の設定
コントロール群:5匹、1mg/kg投与群:5匹、30mg/kg投与群:5匹
(c)試験項目および方法
・体重、摂餌量測定:サツマイモ茎葉抽出物の投与は7日間とし、一般状態についての観察体重および摂餌量は毎日午前10から11時の間に測定した。飼料および給水は自由摂取とした。
・実施例4で得たサツマイモ茎葉抽出物を蒸留水にて溶解し、サツマイモ茎葉抽出物の摂取量が1日あたり1mg/kg、または30mg/kgとなるよう胃ゾンデを用いて経口投与した。Control群については生理食塩水を10mL/kgを投与した。7日目の投与においては、AAPH投与12時間前にサツマイモ茎葉抽出物および生理食塩水を投与した。
・AAPHの投与は生理食塩水を用いて50mg/kg B.Wに調製し、ラットに腹腔内投与した。
・尿サンプルはAAPH投与後より解剖時まで、代謝ケージを用いて採取した。採取した尿については不純物を濾過した後、分析に供するまで−80℃下に保存した。
・解剖については、AAPH投与終了後より12時間の絶食を行い、ペントバルビタール系麻酔薬麻酔下において腹大動脈から採血した。血液は遠心分離(4℃、3000rpm、20分)して血清を採取し、分析に供するまで−80℃下にて凍結保存した。次に肉眼的観察を行った後、脱血処理を施した後に肝臓を摘出し、重量を測定した。重量測定後は、分析に供するまで−80℃下にて凍結保存した。
・生化学検査として、血清については総蛋白、アルブミン、総コレステロール、HDL−コレステロール、LDL−コレステロール、リン脂質、過酸化脂質、AST、ALTを分析し、尿については8−OhdG(8−Hydroxy−deoxyguanosine)を分析した。
・肝臓中の過酸化脂質の測定は、摘出し凍結させた肝臓を解凍後、氷冷下でホモジナイズし、菊川の方法(日本生化学会編 基礎生化学実験法 第5巻 脂質・糖質・複合糖質 東京化学同人)に基づき、チオバルビツール酸(TBA)試験より測定した。なお、結果については各試料中のタンパク質あたりのTBARS(nmol/mg protein)(チオバルビツール酸反応物:thiobarbituric acid reactive substances)として算出した。
・統計処理として、試験結果は平均値±標準誤差で表し、有意差検定はStudent’s−t testを用いた。
結果
(A)一般状態および体重推移
一般状態においては、全例において異常は認められなかった。AAPH投与前7日間の体重推移では、Control群、1mg/kg群およぴ30mg/kg群のいずれの群においても顕著な差は認められなかった。AAPH投与後の状態観察では、投与後、各群において被毛が逆立つ特有の反応が観察された。サツマイモ茎葉抽出物投与群に関しては、その状態からの回復がControl群に比較して早期であった。
(B)摂餌量
試験期間中の摂餌量においては、1mg/kg群で1日目にControl群に対して有意に増加したが、正常範囲の摂餌量であること、翌日より各群間に顕著な差が認められなかったことから、一過性の症状と思われた。
(C)肝臓重量
肉眼的観察においては、Control群で暗黄赤褐色を呈し、軽度に腫大していたのに対してサツマイモ茎抽出物群については正常に近い赤褐色の色調であった。特に、1mg/kg群では30mg/kg群よりも、より正常に近い状態を示した。触診では、Control群では柔らかく各葉の先端部位が鈍角であるのに対して、サツマイモ茎葉抽出物投与群の肝臓は弾力性に富み、各葉の先端部位は鋭角であった。肝臓重量はControl群4.383±0.209gに対して、1mg/kg群では3.911±0.249g、30mg/kg群では4.033±0.316gとサツマイモ茎葉抽出物投与群で低い値を示した。
(D)血清およぴ尿中生化学検査
・血清総蛋白:Control群4.88±0.10g/mLに対し、1mg/kg群5.04±0.05g/mL、30mg/kg群5.00±0.05g/mLと高い値を示した。
・血清アルブミン:Control群2.70±0.05g/mLに対し、1mg/kg群2.90±0.07g/mL、30mg/kg群2.74±0.05g/mLと1mg/kg群でやや高い値を示した。
・血清総コレステロール:Control群40.18±5.55mg/mLに対し、1mg/kg群55.74±2.93mg/mL、30mg/kg群48.40±6.41mg/mLとサツマイモ茎葉抽出物投与群でやや高い値を示した。
・血清HDL−コレステロール:Control群16.20±1.46mg/mLに対し、1mg/kg群22.20±0.58mg/mL、30mg/kg群18.20±2.29mg/mLとサツマイモ茎葉抽出物投与群でやや高く、特に1mg/kg群で高い値を示した。
・血清LDL−コレステロール:Control群2.88±1.29mg/mLに対し、1mg/kg群5.60±1.29mg/mL、30mg/kg群4.00±1.30mg/mLとサツマイモ茎葉抽出物投与群でやや高く、特に1mg/kg群で高い値を示した。
・血清リン脂質:Control群71.98±4.90mg/mLに対し、1mg/kg群84.04±4.16mg/mL、30mg/kg群81.40±4.68mg/mLとサツマイモ茎葉抽出物投与群でやや高く、特に1mg/kg群で高い値を示した。
・血清過酸化脂質:Control群0.84±0.12nmol/mLに対し、1mg/kg群0.68±0.07nmol/mL、30mg/kg群0.58±0.02nmol/mLとサツマイモ茎葉抽出物投与群で低く、特に30mg/kg群で低い値を示した。
・血清AST:Control群204.64±55.85mg/mLに対し、1mg/kg群99.72±23.93mg/mL、30mg/kg群148.40±41.24mg/mLとサツマイモ茎葉抽出物投与群で低く、特に1mg/kg群で低い値を示した。
・血清ALT:Control群70.36±17.56mg/mLに対し、1mg/kg群39.52±5.86mg/mL、30mg/kg群49.00±10.58mg/mLとサツマイモ茎葉抽出物投与群で低い値を示した。
・尿中8−OHdG:Control群41.56±4.90mg/mLに対し、1mg/kg群21.60±2.75mg/mL、30mg/kg群19.88±1.85mg/mLとサツマイモ茎葉抽出物投与群で有意(p<0.05)に低い値を示した。結果を図3(a)に示す。
・肝臓TBARS:Control群0.486±0.035nmol/mg proteinに対し、1mg/kg群0.296±0.025nmol/mg protein、30mg/kg群0.286±0.020nmol/mg proteinとサツマイモ茎葉抽出物投与群で有意(p<0.01)に低い値を示した。結果を図3(b)に示す。
抗酸化作用を検討する指標として、AAPH投与後より解剖時までの12時間採取した尿申の8−OHdG、肝臓中TBARSについて測定した結果、尿中の8−OHdGならび肝臓中TBARSは、Control群に比較して、サツマイモ茎葉抽出物投与群が有意に低い値を示した。解剖時の肉眼的観察では、特に1mg/kg群でその状態が良好であり、肝臓重量についても低い値を示した。さらに、血清生化学検査値では、同様にサツマイモ茎葉抽出物投与群で良好であり、肉眼的観察同様に30mg/kg群よりも1mg/kg群でその傾向を示した。30mg/kg群では、血清過酸化脂質ならびに尿申8−0HdGが1mg/kg群よりも低い値であった。
以上の結果から、サヅマイモ茎葉抽出物は、ラジカル開始剤AAPHを腹腔内に投与することによる生体内脂質過酸化を誘発させたモデル動物において、高濃度摂取では血清過酸化脂質、肝臓中TBARSおよぴ尿中8−OHdG等の過酸化物の産生を有意に抑制する抗酸化作用を示し、また、低濃度摂取では高濃度よりも緩やかな抗酸化作用を示すとともに、肝臓の障害を軽減し肝臓を保護する作用をもつ素材であることが確認された。
(上記結果に関する考察)
上記実験結果は実に驚くべきものであった。つまりここで用いたサツマイモ茎葉抽出物中のポリフェノール類はカテキン換算の含量として約30%であり、体重60kgの人に換算すると0.3×1mg/kg×60kg=18mgとなる。ポリフェノール成分として1日わずか20mg程度の摂取量で機能性を発揮すると予想される。一方、最近脚光を浴びている茶カテキンを比較するとその機能性を発揮する量として人で500mgという値が公表されている(バイオサイエンスとインダストリー Vol.61 No.11 2003)。茶カテキンの機能性としては体脂肪低減作用であり、本発明のサツマイモ茎葉抽出物とは機能性が異なるが、ポリフェノールの有効濃度が茶カテキンより1桁低く、高活性であることはわれわれの予想を越えるものであった。また、2004年度の日本農芸化学会で九州沖縄農業研究センターのグループから紫サツマイモの塊根から調製したアントシアニンを含むサツマイモジュースの四塩化炭素投与による肝機能障害軽減効果に関し報告があった。発表の紫サツマイモのジュースには120mlで12.6gの紫サツマイモ成分が含まれており、投与量としてはアントシアニン換算で1日50mg/kgとなるようであったが、本発明のサツマイモ由来茎葉抽出物の機能性効果はそれと比較して十分に高いと考えられる(2004年度日本農芸化学会 大会要旨集 3A17p10)。
実施例10 チロシナーゼ阻害活性の確認
実施例4で得たサツマイモ茎葉抽出物を用いてチロシナーゼ阻害活性を測定した。その測定方法を下記に示す。
(a)反応試薬
・チロシン溶液(0.5mg/mL):チロシン25mgを蒸留水にて50mLにメスアップし、測定に使用した。
・チロシナーゼ溶液(2500U/mg):マッシュルーム由来のチロシナーゼ(2500U/mg)6mgを蒸留水にて100mLにメスアップし、測定に使用した。
・1/15Mリン酸緩衝液(pH6.8):リン酸二水素カリウム0.9072g蒸留水にて100mLに、リン酸水素ナトリウム2.3876gを蒸留水にて100mLにメスアップした。次に、各々等量を混合した後、pHが6.8であることを確認し測定に使用した。
・50v/v%エタノール溶液:エタノールおよび蒸留水を等量混合し測定に使用した。
(b)試料対象物の調製
実施例4で得たサツマイモ茎葉抽出物10mgを50v/v%エタノール溶液10mLに溶解し、原液とした。次にその原液を用いて、1/15Mリン酸緩衝液(pH6.8)にて0.005mg、0.01mg、0.05mg、0.1mg、0.5mgの量になるよう希釈し、反応に使用した。
(c)チロシナーゼ活性測定
下記の反応系を調製後、37℃で1時間インキュベートし、475nmの吸光度を測定した。対照(Ab)はチロシン溶液(0.5mL)、リン酸緩衝液(4.0mL)、チロシナーゼ溶液(0.5mL)を加え、5.0mLとする。一方、検体(At)はチロシン溶液(0.5mL)、リン酸緩衝液(2.0mL)、チロシナーゼ溶液(0.5mL)、各試験溶液(2.0mL)を加え5mLとする。
(d)チロシナーゼ活性抑制率の算出は下記の計算式で求めた。
抑制率=(Ab−At)/Ab×100
また、試験対象物のチロシナーゼ50%抑制濃度(IC50)を算出した。
サツマイモ茎葉抽出物のチロシナーゼ阻害活性を美白作用が知られるコウジ酸やアスコルビン酸と比較して測定した。その結果を表5に示した。
実施例11 糖吸収抑制効果の確認
実施例4で得たサツマイモ茎葉抽出物を用いて動物実験で糖の吸収抑制作用について、グルコース投与による糖負荷試験を行った。試験の材料と方法を下記に示す。
(a)供試動物
種:ラット、系統:SD、性別:オス、入荷時週齢:4週齢
(b)試験群の設定
コントロール群:5匹、30mg/kg投与群:5匹
(c)試験項目および方法
・体重については、予備飼育期間中のみ毎日午前10から11時の間に測定した。なお、糖負荷試験は前日の体重を考慮して、4群に群分けを行った。
・サツマイモ茎葉抽出物は蒸留水にて各濃度に調製し、胃ゾンデを用いて経口投与した。
・糖負荷試験は、試験前日より18時間絶食後、グルコースを2g/kg経口投与し、投与前(0分)、投与後30、60、90、120分に眼窩静脈叢より採血し、血糖測定機を用いて測定した。なお、サツマイモ茎葉抽出物はグルコース負荷30分前に投与した。また、各測定値をもとに120分間のΔ血糖面積値(AUC:mg/dL・hr)を下記の計算式より算出した。
計算式
AUC(0−T4)=C1T1/2+(C1+C2)(T2−T1)/2+(C2+C3)(T3−T2)/2+(C3+C4)(T4−T3)/2
C1:0分から30分時の血糖上昇値
C2:0分から60分時の血糖上昇値
C3:0分から90分時の血糖上昇値
C4:0分から120分時の血糖上昇値
T:経過時間(hr) T1:0.5hr、T2:1.0hr、T3:1.5hr、T4:2.0hr
・統計処理として、試験結果は平均値±標準誤差で表し、有意差検定はStudent’s−t testを用い、」対照群に対しp<0.05で有意とした。
サツマイモ茎葉抽出物の糖負荷試験の結果について表6に示した。
さらに、上記と同様の条件で、血糖上昇抑制効果について、グアバ葉抽出物との比較試験を行った。試験群は、サツマイモ茎葉抽出物30mg/kg群、100mg/kg群、グアバ葉抽出物100mg/kg群および対照群とし、ラット各5匹で行った。各試験対象物は生理食塩水にて調製し、対照群は生理食塩水のみの投与とした。
上記と同様、試験対象物を投与後、グルコース2g/kg経口投与して、上記と同様の採血スケジュールで採血を行い、血糖値を測定した。各測定値をもとに経時的な血糖濃度のグラフを図5に示した。
グルコース投与30分後において、全ての群で血糖値が最も上昇したが、サツマイモ茎葉抽出物群およびグアバ葉抽出物群は、対照群と比較して血糖値上昇の直線の傾きが緩やかであり、各群とも糖吸収を抑制していることが推認された。サツマイモ茎葉抽出物30mg/kg群は、グアバ葉抽出物100mg/kg群と同程度の血糖値の推移を示し、サツマイモ茎葉抽出物の30mg/kg群と100mg/kg群とでは、用量依存的に血糖値上昇抑制を示した。以上より、サツマイモ茎葉抽出物は、グアバ葉抽出物と比較して、より強力な血糖上昇抑制作用を有していることが示唆された。
実施例12 脂肪吸収抑制作用の確認
実施例4で得たサツマイモ茎葉抽出物を用いて動物実験で脂肪吸収抑制作用について、大豆油投与による脂肪負荷試験を行った。試験の材料と方法を下記に示す。
(a)供試動物
種:ラット、系統:SD、性別:オス、入荷時週齢:4週齢
(b)試験群の設定
コントロール群:5匹、30mg/kg投与群:5匹
(c)試験項目および方法
・体重については、予備飼育期間中のみ毎日午前10から11時の間に測定した。なお、脂肪負荷試験は前日の体重を考慮して、4群に群分けを行った。
・サツマイモ茎葉抽出物は蒸留水にて各濃度に調整し、胃ゾンデを用いて経口投与した。
・脂肪負荷試験は、試験前日より18時間絶食後、植物(大豆)油を2g/kg経口投与し、投与前(0分)、投与後30、60、120、180、240、300分に眼窩静脈叢より採血した。その血液は遠心分離(4℃、3000rpm、20分)して血漿を採取し、市販キットを用いてトリグリセライド濃度を測定した。なお、サツマイモ茎葉抽出物は植物油投与直前に投与した。また、各測定値をもとに300分間のΔ中性脂肪面積値(AUC:mg/dL・hr)を下記の計算式より算出した。
計算式
AUC(0−T4)=C1T1/2+(C1+C2)(T2−T1)/2+(C2+C3)(T3−T2)/2+(C3+C4)(T4−T3)/2+(C4+C5)(T5−T4)/2+(C5+C6)(T6−T5)/2
C1:0分から30分時の中性脂肪上昇値
C2:0分から60分時の中性脂肪上昇値
C3:0分から120分時の中性脂肪上昇値
C4:0分から180分時の中性脂肪上昇値
C5:0分から240分時の中性脂肪上昇値
C6:0分から300分時の中性脂肪上昇値
T:経過時間(hr) T1:0.5hr、T2:1.0hr、T3:2hr、T4:3hr、T5:4hr、T6:5hr
・統計処理として、試験結果は平均値±標準誤差で表し、有意差検定はStudent’s−t testを用い、」対照群に対しp<0.05で有意とした。
サツマイモ茎葉抽出物の脂肪負荷試験の結果について表7に示した。
植物油投与180分、240分後では、サツマイモ茎葉抽出物投与群は対照群と比較して低い値を示し、180分時では有意差も認められた。300分後においては、群間差は認められなかった。以上からサツマイモ茎葉抽出物の脂肪吸収抑制作用が確認された他、吸収遅延作用も有する可能性が考えられる。
さらに上記と同様の条件で、脂肪吸収抑制作用について、緑茶抽出物(ポリフェノール含量30%)との比較試験を行った。試験群は、サツマイモ茎葉抽出物30mg/kg群、100mg/kg群、緑茶抽出物30mg/kg群および対照群とし、ラット各5匹で行った。各試験対象物は生理食塩水にて調製し、対照群は生理食塩水のみの投与とした。上記と同様、試験対象物を投与後、食後に植物(大豆)油を2mg/kg経口投与し、上記と同様の採血スケジュールで採血を行い、トリグリセ
mg/dL・hr)を上記のとおり計算し、図7に示した。
サツマイモ茎葉抽出物投与群および緑茶抽出物(ポリフェノール含量30%)投与群はいずれも対照群と比較して、大豆油の摂取により増加する血液中の中性脂肪の量を有意に低下させた。サツマイモ茎葉抽出物と緑茶抽出物の各30mg/kg投与群とを比較すると、サツマイモ茎葉抽出物のほうが、血液中の中性脂肪低下作用が大きいことが分かる。また、サツマイモ茎葉抽出物投与群では、用量依存的に中性脂肪の量を低下させた。以上より、サツマイモ茎葉抽出物は、緑茶抽出物と比較しても、より強力に中性脂肪吸収抑制作用を発揮していることが示唆された。
実施例13 サツマイモ茎葉抽出物の毒性試験
実施例4で得たサツマイモ茎葉抽出物の単回投与による経口毒性を検討するため、0mg/kg(対照群)および2000mg/kgの用量で、各用量当たりSD系ラット雌雄各5匹に1回投与し、14日間観察した。投与液は所定量のサツマイモ茎葉抽出物を秤量し、媒体である2v/v%Tween80水溶液に懸濁させ、投与液とした。投与液は投与当日に一回調製した。観察・測定項目として、一般状態の観察(投与前、投与後30分、1、3、5時間、その後は1日1回、14日間観察)、体重測定(投与直前、第2,4,8,15日に電子上皿天秤を用いて測定)、病理学的検査(第15日に全例をチオペンタールナトリウムの腹腔内投与による麻酔下で腹大動脈を切断・放血し、安楽死させた後剖検)を行った。いずれの群でも死亡例は発現せず、観察期間中、何ら毒性症状も発現しなかった。また、剖検でもなんら異常所見は得られなかった。
実施例14 サツマイモ葉抽出物を含有する飲料水(熱水抽出物)の作製
焙煎工程を加えることによって、サツマイモ茎葉抽出物の抗酸化性を保持した範囲でサツマイモ茎葉抽出物の味を整えることができる。焙煎する温度や時間を調節することにより、焙煎の程度を調節することが可能である。
サツマイモ葉(乾燥物)を裁断機にてカットし、鍋にて中程度(2分30秒)に焙煎後、熱水(80℃)に20分浸漬し、サツマイモ葉抽出物を含有する飲料水を作成した。シロユタカは葉が大きく、さらに乾燥重量も大きいことから、焙煎等の工程においても扱いやすかった。焙煎工程を経ることによって、焙煎しない場合と比較して、飲料水(サツマイモ茎葉抽出物)に香ばしい香りと味を付与することができた。これはサツマイモ葉に含まれるクロロゲン酸の分解産物であるキナ酸が生じたことも、その一因であると考えられる。また、抽出する水の温度によっても微妙に味や香りを変化させることができる。焙煎したサツマイモ茎葉は本発明の抽出原料として使用することも可能であるが、例えばティーパックに焙煎したサツマイモ茎葉を4グラムずつ包装し、およそ2リットルのお湯に浸漬することで手軽に飲料水(サツマイモ茎葉抽出物)を得ることができ、サツマイモ茎葉抽出物の様々な優れた効果を発揮することのできる、香り、味とも良好な飲料水を製造することができる。
実施例15 サツマイモ茎葉抽出物の変異原性試験
(1)エームス試験
医薬品遺伝毒性試験ガイドラインに準拠した「エームス試験」により試験管内での変異原性の効果判定を行った。検定菌として,Salmonella typhimurium(TA100,TA98,TA1535,TA1537)およびEscherichia coli(WP2uvrA/pKM101)の5菌株を用いた。実施例4で得たサツマイモ茎葉抽出物(被験検体)5000μg/プレートを最高用量とし、S9mix添加、無添加群、各6段階(1.22〜500)にて用量反応性試験を行ったが、菌の生育阻害は見られなかったため、本試験でも5000μg/プレートを最高用量として5用量を設定して実施し、各濃度での復帰突然変異コロニー数を測定した。その結果、Ames試験の判定法に準じ、いずれの検定菌においてもS9mixの有無にかかわらず変異原性は陰性と判断された。
(2)小核試験
医薬品遺伝毒性試験ガイドラインに準拠した「げっ歯類を用いた小核試験」により、サツマイモ茎葉抽出物の生体内での変異原性の効果判定を行った。実施例4で得たサツマイモ茎葉抽出物(被験検体)500、1000および2000mg/kgを、雄性ラット(7週令、5匹/群)に各用量3例を用いて2回強制経口投与(24時間間隔)した結果、いずれの群においても死亡は認められず、一般状態にも変化はなかった。したがって、本試験では被験検体については同じ濃度とし、陽性対象にシクロホスファミド10mg/kg、陰性対象に生理食塩水を加えて実施することとした。最終投与24時間後、被験動物の大腿骨より骨髄細胞を採取して組織標本を作製した。全赤血球中の小核を持つ赤血球の割合を定法にて測定し、統計処理を施した結果、被験検体に関して小核の出現頻度は統計学的に有為でなく変異原性は陰性と判断された。
以上より、いずれの試験においても、サツマイモ茎葉抽出物の変異原性は陰性という結果であり、サツマイモ茎葉抽出物の摂取によって突然変異を起こす可能性は低く、極めて安全性が高いことが示唆された。
実施例16 サツマイモ茎葉抽出物の脱臭効果試験
ヒトやペットの口臭、体臭、便臭等の原因物質に対する消臭効果を検討した。
(1)300mlのコニカルビーカーに100ml純水にアンモニア、トリメチルアミン、メルカプタンを添加し、アルミホイルで蓋をした。
(2)ヘッドスペース部を各成分の濃度を検知管にて測定し、実施例4で得たサツマイモ茎葉抽出物を1g入れ攪拌し、ヘッドスペース部の各成分の濃度を検知管にて測定した。
測定結果を図8に示した。アンモニア、トリメチルアミンはサツマイモ茎葉抽出物を添加した直後に臭気は感じられず、濃度も検出限界以下となった。また、メチルメルカプタンについては、サツマイモ茎葉抽出物添加直後に部分的に分解され、減臭効果が認められた。以上より、サツマイモ茎葉抽出物は異なる種類の臭気に対しても脱臭効果を発揮することが示唆された。サツマイモ茎葉抽出物は本発明の安全性試験によって、生体に対して極めて安全性が高いことが確認されていることから、ヒトやペットの口臭、体臭、便臭に対する消臭、飲食品の消臭等にも使用することができ、脱臭効果を有する物質の中でも、極めて幅広い応用範囲で使用可能な物質であるといえる。
実施例17 ラット白色脂肪細胞を用いた脂肪細胞分化および肥大化抑制試験
脂肪細胞の増加抑制効果を調べるため、in vitroにおけるラット腸間膜由来白色脂肪細胞の分化および肥大化抑制試験を行った。
ラット白色脂肪細胞の脂肪細胞分化および肥大化抑制の観察
ラット白色脂肪細胞キット((株)セルガレージ)の脂肪細胞を使用し、操作は全て通常の方法に従い行った。まず、脂肪細胞を増殖用培地中で5%CO2下24時間インキュベーションを行った。脂肪細胞が2×105cells/wellになるように24wellプレートに播種し、24時間インキュベーションした後、分化誘導培地に交換し、5%CO2下48時間インキュベーションした。さらに脂肪細胞維持培地に交換した後、各試験対象物として、実施例4で得たサツマイモ葉抽出物100μg/mL、緑茶抽出物(90%カテキン)100μg/mLを培地中の脂肪細胞に添加し、何も添加しないものをコントロールとして、5%CO2下インキュベーションをし、24hごとに細胞の状態を観察した。
各群の脂肪細胞の24時間後、72時間後、96時間後における状態を図9に示した。その結果、サツマイモ茎葉抽出物および緑茶抽出物は両者ともコントロールと比較して、全ての時間にわたり、顕著に脂肪細胞の脂肪滴の蓄積および脂肪細胞の肥大化を抑制した。サツマイモ茎葉抽出物と緑茶抽出物とを比較すると、24時間後には緑茶抽出物のほうが脂肪滴の蓄積はやや少ないものの、48時間後(データは示さない)および72時間後には両者同等となり、96時間後は両者同等か、もしくはわずかにサツマイモ茎葉抽出物のほうが脂肪細胞の肥大化を抑制した。以上より、サツマイモ茎葉抽出物は、緑茶エキスと比較しても、ほぼ同等か、それ以上の脂肪細胞の分化および肥大化抑制効果効果を有することが分かった。従って、本発明のサツマイモ茎葉抽出物は、脂肪細胞の分化および肥大化が原因となって生じる肥満の予防・治療剤として利用できる可能性が示唆された。
実施例18 マウス強制水泳法による抗うつ作用および抗疲労作用の検討
マウス強制水泳法により、サツマイモ茎葉抽出物の抗うつ作用および抗疲労作用の検討を行った。
マウス(BALB/c系統・雄・7週齢)は、本試験開始前日まで7日間予備飼育を行い馴化した。予備飼育終了2日前に供試動物を5分間強制遊泳させ、試験対象物投与前の遊泳状態が均一になるようにスクリーニングを行い、予備飼育最終日の体重も考慮して、供試動物6匹ずつ群分けを行い、本試験を開始した。試験群は、実施例4で得たサツマイモ葉抽出物 30mg/kg群、300mg/kg群、セントジョーンズワート300mg/kgおよび対象群とした。各試験対象物は生理食塩水にて調製し、胃ゾンデを用いて強制経口投与(10mL/kg)した。なお、コントロール群については、生理食塩水を同様に強制経口投与(10mL/kg)した。試験対象物を投与してから、1時間後に10Lの温水(37℃)を満たしたアクリル製水槽(350×400×180mm)中で遊泳させ、遊泳状態を観察した。判定は、下記基準に準拠して持続時間を測定した。
判定基準
EDB(escape directed behavior): 水槽より跳び出ようとする行動、あるいは潜水して出口を捜し求めるような行動
IMO(immobility): ほとんどの動きを停止し、単に浮遊しているだけの状態
各群のEDBおよびIMO時間の平均値を図10に示した。サツマイモ茎葉抽出物およびセントジョーンズワート抽出物投与群は、コントロール群に対してEDBの有意な延長とIMOの有意な短縮が認められた。また、サツマイモ茎葉抽出物投与群については濃度依存的な効果を示し、サツマイモ茎葉抽出物300mg/kg群はセントジョーンズワート300mg/kg群とほぼ同等の効果がみられた。セントジョーンズワートは、気分をリラックスさせ、ストレスに効果のあるハーブとして広く知られ、ドイツでは、軽〜中等度のうつ症状に対して、実際に抗うつ薬として使用されている。サツマイモ茎葉抽出物群はセントジョーンズワート群と同様に、強制的な運動負荷や精神的ストレスに対して有効であったことから、サツマイモ茎葉抽出物は、単回経口投与でも十分に、精神的および肉体的なストレス、疲労に対して有効であり、セントジョーンズワートとほぼ同等の、抗うつ作用、抗ストレス作用、リラックス作用を有することが示唆された。
実施例19 油脂安定性試験
実施例4で得たサツマイモ茎葉抽出物をビタミンEフリーの豚脂3gに対し、それぞれ200ppm、1000ppmとなるように添加し、試料液とした。乾燥空気流量20L/hr、温度120℃下、試料液を自動油脂安定性試験装置(CDM試験装置)により、油脂の変敗開始時間を求めた。
サツマイモ茎葉抽出物の濃度における変敗時間を図11に示した。サツマイモ茎葉抽出物は、0ppmで1.6時間であった変敗時間を、200ppmで豚脂の変敗時間を2倍(3.3時間)に延長し、1000ppmで3倍(5時間)に延長した。以上より、サツマイモ茎葉抽出物は、豚脂・ラードなどの動物脂質を使用する加工食品(フライドポテトやスナック、カップ麺等)をはじめ、その他様々な油脂類に添加し、油脂の劣化防止に応用できる可能性が示唆された。
実施例20 サツマイモ茎葉抽出物を用いた製剤の作製
本発明のサツマイモ茎葉抽出物を用いて、下記の3種類の製剤を作製した。
(1)顆粒剤の作製
下記の表8のとおり、サツマイモ茎葉抽出物を終濃度5%となるように各種賦形剤と混合し、合計2kgの原料を適量の水を加えて練合の上、噴霧乾燥造粒機を用いて顆粒剤を作製した。製造した顆粒剤は2グラムごとにアルミ包装した。本品は携帯に便利であり、水溶性も良好であるため、用時100mL程度のお湯あるいは水に溶解することで美味しく飲料化することができた。本品は1包当たりサツマイモ茎葉抽出物100mgを含有する。
下記の表9のとおり、サツマイモ茎葉抽出物1kgを終濃度20%となるように各種賦形剤と混合し、合計5kgの原料をもとに適量の水を加えて練合の上、打圧式の錠剤製造機を用いて1錠250mgの錠剤を作成した。本品は1錠当たりサツマイモ茎葉抽出物50mgを含有する。
下記の表10のとおり、サツマイモ茎葉抽出物10gをグミ基剤1kgと加熱下混合し、糖度が80%程度になるまで煮詰める。クエン酸液ならびに果汁及び香料を加え、熱いうちに一粒5gに成型した(サツマイモ茎葉抽出物終濃度0.1%)。本品は1粒当たりサツマイモ茎葉抽出物5mgを含有する。
Example 1 Examination of extraction conditions of sweet potato stem and leaf extract
In the production of sweet potato stem and leaf extract, it was investigated how the extraction efficiency of polyphenols varied with ethanol concentration. Shiroyutaka was used as a sweet potato variety, and the stems and leaves of 4 months of cultivation were harvested, and those dried on the sun were crushed and used for extraction. The extraction and purification operation was performed according to the following procedure.
(1) As an examination of conditions, 90 g of dried and crushed sweet potato stalks and leaves were used under one extraction condition.
(2) As the setting of extraction conditions, examination was performed under five conditions with different ethanol concentrations (0% (water), 20%, 40%, 60%, 80%).
(3) Extraction is performed by leaving the first 700 ml of the extract at room temperature for 12 hours, followed by filtration, collecting the filtrate, adding 500 ml of the extract to the extraction residue, and performing the extraction for 12 hours. It was. Thereafter, the same operation was performed, extraction was performed three times in total, and the collected extracts were combined.
(4) The extract was concentrated to about 200 ml with a rotary evaporator, and then fractionated with 50 ml of hexane to collect the aqueous layer portion.
(5) Purification was performed using DIAION HP20 sold by Mitsubishi Chemical. A column was prepared by replacing 50 g of DIAION HP20 with water, and the collected aqueous layer portion was passed through the column. Thereafter, the column was washed with about 500 ml of water and the polyphenol fraction was eluted with about 250 ml of 90% ethanol and collected.
(6) The collected polyphenol fraction was measured for the amount of polyphenol and concentrated to dryness, and the weight was measured.
The collected polyphenol fraction was measured for polyphenol content in terms of catechin using a polyphenol measuring device (PA-20) sold by Toyobo Engineering Co., Ltd.
Next, the stability of polyphenols in the extract was examined. Regarding the stability, the polyphenol concentration immediately after extraction was compared with the polyphenol concentration after being left indoors for 12 days, and the rate of decrease in concentration was used as an indicator of stability. The results are shown in Table 2.
Example 2 Examination of purity improvement method of polyphenol
In functional foods, it is important to increase the purity of functional ingredients at no cost. For example, undesirable components such as astringency may be included in impurities, and relatively undesirable components can be reduced by increasing the purity. Therefore, extraction was carried out separately for the stems and leaves of sweet potato, and after concentration, a method for removing precipitates that occurred with time was studied. The following items were examined as examination conditions.
(A) A stem of sweet potato was separated, a polyphenol fraction was obtained by the method of Example 1 using 60% ethanol, and the amount of polyphenol per dry weight, that is, the purity of the fraction was examined. However, the hexane fraction in Example 1 was omitted.
(B) The leaves of sweet potato were separated, a polyphenol fraction was obtained by the method of Example 1 using 60% ethanol, and the amount of polyphenol per dry weight, that is, the purity of the fraction was examined. However, the hexane fraction in Example 1 was omitted as in (a).
(C) The sweet potato leaf was separated and extracted by the method of Example 1 using 60% ethanol to obtain 200 ml of a concentrated solution. The concentrated solution was allowed to stand for 3 days, and then the precipitate formed in 3 days was removed. The removed product was passed through an HP-20 column and the polyphenol fraction was collected in the same manner as in Example 1. Then, the amount of polyphenol per dry weight of the fraction, that is, the purity was examined. However, the hexane fraction in Example 1 was omitted as in (a).
(D) The sweet potato leaves were separated and extracted by the method of Example 1 using 60% ethanol to obtain 200 ml of concentrated liquid. About 4 times the volume of ethanol was added to the concentrated liquid and left for 3 days. After removing the precipitate produced in 3 days, ethanol was removed again by a rotary evaporator, and then the mixture was passed through an HP-20 column and the polyphenol fraction was collected in the same manner as in Example 1. Then, the amount of polyphenol per dry weight of the fraction, that is, the purity was examined. However, the hexane fraction in Example 1 was omitted as in (a).
The results are shown in Table 3.
Example 3 Retrieval of components by liquid chromatography
The components of the polyphenol fraction (sweet potato foliage extract) extracted and fractionated from sweet potato foliage or leaves by the method of Example 1 using 60% ethanol were searched for by liquid chromatography. Conditions are shown below.
Condition: Column: Shima-pack VP-ODS (manufactured by Shimadzu)
Column temperature: 40 ° C
Eluent: Solution A 4.5 mM citrate water: Acetonitrile: Isopropanol
100: 10: 3
B liquid 6 mM citric acid water: acetonitrile: isopropanol
100: 47: 3
Eluent gradient: Time A / B
0min 85/15
40min 0/100 (linear gradient)
50min 0/100
60min 85/15 (linear gradient)
FIG. 1 shows a liquid chromatography chart of the sweet potato stem and leaf extract obtained by the method of Example 1 using 60% ethanol from the sweet potato stem and leaf. From the analysis of the peaks, the extract contains quercetin-3-glucoside, quercetin-3-galactoside, chlorogenic acid and three dicaffeoylquinic acids (3,4-dicaffeoylquinic acid, 3,5-diacid). Caffeoylquinic acid, 4,5-dicaffeoylquinic acid) was found to be contained. FIG. 2 shows a liquid chromatography chart of the sweet potato stem and leaf extract obtained by the method of Example 1 using 60% ethanol from sweet potato leaves. It was found that the extract using only leaves contained a large amount of quercetin-3-glucoside and quercetin-3-galactosid.
Example 4 Production of sweet potato stem and leaf extract using 80% ethanol
A sweet potato shoot extract was produced by the following method.
(1) Put 2.22 kg of dried potato leaves and leaves into a 20 L extractor, add 13.2 L of 80% ethanol, perform warm extraction (75 ° C.) for 2 hours, and filter with Nutsche to obtain about 10 L of extract. It was.
(2) Further, the same operation is performed three times. An extract 40L was obtained. The extract was concentrated to about 1/7 under reduced pressure.
(3) After adding 8.0 L of hexane and separating the fat-soluble component, the hexane layer was removed.
(4) The solvent was distilled off from the aqueous layer portion under reduced pressure until the solution was about 5 L.
(5) 5 L of water was added to the concentrated solution. Since impurities accumulated in the lower layer of the diluted solution, insoluble matters were removed by decantation.
(6) After passing the supernatant liquid through 3 L of the adsorption resin (HP20), the resin was washed with 4 L of water.
(7) The adsorbate was eluted from the resin with 10 L of 90% ethanol.
(8) The eluate was evaporated to dryness under reduced pressure, and 54.43 g (yield 2.45%) of a powder sample was obtained using a spray dryer.
The obtained powder sample (sweet potato stem and leaf extract) had a polyphenol content of about 34% in terms of catechin, and the quercetin-3-glucoside content in the polyphenol was 5.6%. Further, it was confirmed by liquid chromatography that quercetin-3-glucoside, quercetin-3-galactoside, chlorogenic acid and dicaffeoylquinic acid were contained in the same manner as in Example 3.
Example 5 Production of sweet potato stem and leaf extract using 60% ethanol
1.5 kg of dried sweet potato stalks and leaves were crushed, 6.1 L of 60% ethanol was added, extraction was performed for 2 hours or more, and the primary extract was squeezed to recover 3.5 L. The same amount of 60% ethanol as the primary juice was added and left for 12 hours or longer, and then the secondary extract was squeezed to recover 3.34 L. The primary extract and the secondary extract were combined and concentrated under reduced pressure to about 1/3 volume (2.3 L) using a rotary evaporator. The oily component adhering to the wall surface was removed by decantation, and twice the amount of 100% ethanol was added to the resulting aqueous solution and left for 12 hours or longer. The precipitate (which seems to be a polysaccharide or the like) was removed by decantation, and the supernatant was concentrated under reduced pressure to about 1/7 volume (990 ml) with a rotary evaporator. The resulting aqueous solution was passed through a DIAION HP20 (Mitsubishi Chemical) column. After washing with 5 times the column volume of water, it was eluted with 90% ethanol twice the column volume, and the eluate was dried with a spray dryer to obtain a sweet potato shoot extract. The extract yield from the dried foliage was 0.66%, the polyphenol content in the extract was 41.3%, and the quercetin-3-glucoside content in the polyphenol was 3.0%. Further, it was confirmed by liquid chromatography that quercetin-3-glucoside, quercetin-3-galactoside, chlorogenic acid and dicaffeoylquinic acid were contained in the same manner as in Example 3.
Example 6 Comparison of extraction methods
The quercetin-3-glucoside extract amount was compared for 60% ethanol extraction, hot water extraction, and water extraction.
(1) 60% ethanol extraction
The dried sweet potato stalks and leaves were extracted with 60% ethanol, concentrated with a rotary evaporator, applied to an HP20 column, the fraction eluted with 90% ethanol was dried, and the amount of quercetin-3-glucoside extracted was measured.
(2) Hot water extraction and ethanol precipitation
Extract the dried sweet potato stems and leaves with hot water at 90 ° C, add twice the amount of 100% ethanol, remove the resulting precipitate, concentrate on a rotary evaporator, apply to a HP20 column, and dry the fraction eluted with 90% ethanol. After solidification, the amount of quercetin-3-glucoside extracted was measured.
(3) Hot water extraction
The dried sweet potato stems and leaves were extracted with hot water at 90 ° C., concentrated on a rotary evaporator, applied to an HP20 column, the fraction eluted with 90% ethanol was dried, and the amount of quercetin-3-glucoside extracted was measured.
(4) Water extraction
Extract the dried sweet potato stems and leaves with water, add twice the amount of 100% ethanol, remove the resulting precipitate, concentrate on a rotary evaporator, apply to an HP20 column, dry the fraction eluted with 90% ethanol, and dry the quercetin The amount of -3-glucoside extracted was measured. The results are shown in Table 4.
A large amount of insoluble components in ethanol is extracted by hot water extraction. This substance is considered to be insolubilized during elution with 90% ethanol during the column purification process. Even though the column was washed with water, it strongly bound to the resin during elution with 90% ethanol. , Brown color is not lost. This was expected to affect column regeneration. Subsequently, when a double amount of 100% ethanol was added to the hot water extract or the water extract to obtain an ethanol concentration of 67%, a large amount of hazy and sticky precipitate was deposited. When column purification was performed after filtering the precipitate, pigmentation on the column was not observed. However, the manufacturing method in which a column purification process is added to hot water extraction and water extraction is inferior to 60% ethanol extraction in the amount of quercetin-3-glucoside extraction. Therefore, it is judged that the superiority is low in terms of extraction efficiency compared with 60% ethanol extraction.
Example 7 Comparison of foliage components of various sweet potato varieties
The polyphenol components contained in the foliage were compared between the sweet potato cultivar Shiroyutaka used in Examples 1 to 6, and the four cultivars Koganesengan, SUKUH, Murasaki Tanegashima and Shimo-imo. Shiroyutaka, Koganesengan, SUKUH, and Tanegashima purple extracted the dried sweet potato foliage with 60% ethanol and filtered the sample for HPLC analysis. For Simian potato, a sample of commercially available tea (tea using leaves and leaves) extracted with 60% ethanol and filtered was subjected to HPLC analysis.
As a result, there was no significant difference in the types of components detected by chromatography between Shiroyutaka and the other four varieties, and the types of substances contained were considered to be equivalent. Slightly different. Moreover, it turned out that the sweet potato leaf extract using only a white hawk leaf contains many quercetin-3-glucoside compared with the extract of other varieties.
Example 8 Confirmation of antioxidant capacity
Antioxidant ability was measured using sweet potato stem and leaf extract.
(1) Superoxide scavenging activity
The superoxide scavenging activity of the sweet potato foliage extract obtained in Example 4 was measured by the electron spin reaction (ESR) method. The result is 3.9 × 104Unit / g (unit defined in J. Biol. Chem., 244, 6049 (1969)), and it was confirmed that sweet potato polyphenol has an antioxidant ability. Pycnogenol (1.6 × 10 6), which is said to have very high antioxidant ability, although it has a high level of antioxidant ability.5Compared with the unit / g), it was about a quarter.
(2) DPPH radical scavenging ability
The DHHP radical scavenging ability of the sweet potato stem and leaf extract obtained in Example 4 and the stem-only extract or leaf-only extract obtained in Example 2 was measured by an electron spin reaction (ESR) method. The sweet potato stem and leaf extract obtained in Example 4 was 653 μmol / g, the stem-only extract obtained in Example 2 was 304 μmol / g, and the leaf-only extract obtained in Example 2 was 1273 μmol / g ( The activity is expressed as an equivalent amount of Trolox μmol per 1 g of sample). In commercial tea powder, it is said to be about 515 μmol / g, and the sweet potato shoot extract showed activity equivalent to or better than tea powder.
(3) Hydroxyl radical scavenging ability
About the sweet potato stem and leaf extract obtained in Example 4 and the stem-only extract or leaf-only extract obtained in Example 2, the ability to scavenge the hydroxy radicals generated in the hydrogen peroxide-2valent iron ion system Measurement was performed by a spin trapping method using DMPO. The sweet potato stem and leaf extract obtained in Example 4 was 10.8 mmol / g, the stem only extract obtained in Example 2 was 16.8 mmol / g, and the leaf only extract obtained in Example 2 was 14.4 mmol. (Activity is expressed in terms of mmol of mannitol per gram of sample). It is said that the commercially available tea powder is about 9.3 mmol / g, and the sweet potato shoot extract showed an activity equal to or better than that of the tea powder.
Example 9 Liver Protective Action of Sweet Potato Forage Extract
When the sweet potato stem and leaf extract was ingested in food and beverages, the ingredients were absorbed from the intestinal tract and transferred to the blood, and it was confirmed whether or not free radicals could actually be eliminated in the body. 2,2'-azobisamidinopropane dihydrochloride (AAPH), which is a radical initiator, was administered intraperitoneally to rats administered with a sweet potato foliage extract and untreated rats, and the effects thereof were examined. The test materials and methods are shown below.
(A) Test animal
Species: Rat, Strain: SD, Gender: Male, Age at arrival: 6 weeks old
(B) Test group setting
Control group: 5 animals, 1 mg / kg administration group: 5 animals, 30 mg / kg administration group: 5 animals
(C) Test items and methods
-Measurement of body weight and food consumption: Administration of the sweet potato foliage extract was carried out for 7 days, and the observed body weight and food consumption for the general state were measured every day from 10 am to 11 am. Feed and water were ad libitum.
-The sweet potato foliage extract obtained in Example 4 was dissolved in distilled water and orally administered using a stomach tube so that the intake of the sweet potato foliage extract was 1 mg / kg or 30 mg / kg per day. For the Control group, 10 mL / kg of physiological saline was administered. In the administration on the 7th day, the sweet potato foliage extract and physiological saline were administered 12 hours before the administration of AAPH.
-Administration of AAPH is 50 mg / kg B. using physiological saline. W was prepared and administered intraperitoneally to rats.
-Urine samples were collected using metabolic cages after AAPH administration until dissection. The collected urine was stored at −80 ° C. until it was analyzed after impurities were filtered.
-For dissection, fasting was performed for 12 hours after the end of AAPH administration, and blood was collected from the abdominal aorta under anesthesia with a pentobarbital anesthetic. Blood was centrifuged (4 ° C., 3000 rpm, 20 minutes) to collect serum, and stored frozen at −80 ° C. until analysis. Next, after macroscopic observation, the blood was removed and the liver was removed and weighed. After the weight measurement, the sample was stored frozen at -80 ° C. until analysis.
As a biochemical test, serum was analyzed for total protein, albumin, total cholesterol, HDL-cholesterol, LDL-cholesterol, phospholipid, lipid peroxide, AST, ALT, and urine for 8-OhdG (8-Hydroxy- deoxyguanosine) was analyzed.
・ Measurement of lipid peroxide in the liver is performed by thawing the extracted and frozen liver and homogenizing it under ice-cooling. The method of Kikukawa (Basic Biochemical Experimental Method,
-As a statistical process, the test result was represented by the average value +/- standard error, and Student's-t test was used for the significant difference test.
result
(A) General condition and weight transition
In the general state, no abnormality was observed in all cases. In the body weight transition for 7 days before AAPH administration, no significant difference was observed in any of the Control group, 1 mg / kg group and 30 mg / kg group. In the observation of the state after administration of AAPH, a unique reaction was observed in which the hairs turned upside down in each group after administration. Regarding the sweet potato foliage extract administration group, recovery from that state was earlier than that of the Control group.
(B) Food intake
In the amount of food intake during the test period, the 1 mg / kg group increased significantly compared to the Control group on the first day. However, there was a significant difference between the groups from the following day that the amount was within the normal range. Since it was not observed, it seemed to be a transient symptom.
(C) Liver weight
Macroscopically, the control group exhibited a dark yellow-reddish brown color and was slightly swollen, whereas the sweet potato stalk extract group had a red-brown color near normal. In particular, the 1 mg / kg group showed a more normal state than the 30 mg / kg group. By palpation, the control group was soft and the tip part of each leaf was obtuse, whereas the liver of the sweet potato shoot extract administration group was highly elastic and the tip part of each leaf was acute. Liver weight is low in the control group 4.383 ± 0.209 g, 3.911 ± 0.249 g in the 1 mg / kg group and 4.033 ± 0.316 g in the 30 mg / kg group, which is lower in the sweet potato foliage extract administration group The value is shown.
(D) Serum and urine biochemistry
Serum total protein: Control group 4.88 ± 0.10 g / mL, 1 mg / kg group 5.04 ± 0.05 g / mL, 30 mg / kg group 5.00 ± 0.05 g / mL Indicated.
Serum albumin: 2.70 ± 0.05 g / mL for the control group, 2.90 ± 0.07 g / mL for the 1 mg / kg group, 2.74 ± 0.05 g / mL for the 30 mg / kg group, and the 1 mg / kg group A slightly high value was shown.
Serum total cholesterol: Extraction of sweet potato foliage with control group 40.18 ± 5.55 mg / mL, 1 mg / kg group 55.74 ± 2.93 mg / mL, 30 mg / kg group 48.40 ± 6.41 mg / mL A slightly higher value was shown in the substance administration group.
Serum HDL-cholesterol: Control group 16.20 ± 1.46 mg / mL, 1 mg / kg group 22.20 ± 0.58 mg / mL, 30 mg / kg group 18.20 ± 2.29 mg / mL and sweet potato foliage It was slightly higher in the extract administration group, particularly high in the 1 mg / kg group.
Serum LDL-cholesterol: Control group 2.88 ± 1.29 mg / mL, 1 mg / kg group 5.60 ± 1.29 mg / mL, 30 mg / kg group 4.00 ± 1.30 mg / mL and sweet potato foliage It was slightly higher in the extract administration group, particularly high in the 1 mg / kg group.
Serum phospholipids: Extraction of sweet potato foliage with control group 71.98 ± 4.90 mg / mL, 1 mg / kg group 84.04 ± 4.16 mg / mL, 30 mg / kg group 81.40 ± 4.68 mg / mL It was slightly higher in the product administration group, particularly high in the 1 mg / kg group.
Serum lipid peroxide: control group 0.84 ± 0.12 nmol / mL, 1 mg / kg group 0.68 ± 0.07 nmol / mL, 30 mg / kg group 0.58 ± 0.02 nmol / mL and sweet potato foliage It was low in the extract administration group, and particularly low in the 30 mg / kg group.
Serum AST: 99.72 ± 23.93 mg / mL in the 1 mg / kg group and 148.40 ± 41.24 mg / mL in the 30 mg / kg group for the control group 204.64 ± 55.85 mg / mL It was low in the administration group, particularly low in the 1 mg / kg group.
Serum ALT: Sweet potato stover extract with control group 70.36 ± 17.56 mg / mL, 1 mg / kg group 39.52 ± 5.86 mg / mL, 30 mg / kg group 49.00 ± 10.58 mg / mL A low value was shown in the administration group.
・ Urine 8-OHdG: Control group 41.56 ± 4.90 mg / mL, 1 mg / kg group 21.60 ± 2.75 mg / mL, 30 mg / kg group 19.88 ± 1.85 mg / mL, sweet potato A significantly low value (p <0.05) was shown in the foliage extract administration group. The results are shown in FIG.
Liver TBARS: Control group 0.486 ± 0.035 nmol / mg protein, 1 mg / kg group 0.296 ± 0.025 nmol / mg protein, 30 mg / kg group 0.286 ± 0.020 nmol / mg protein and sweet potato A significantly low value (p <0.01) was shown in the foliage extract administration group. The results are shown in FIG.
As an index for studying the antioxidant action, as a result of measurement of 8-OHdG and TBARS in the liver collected for 12 hours from the time of AAPH administration to the time of dissection, urinary 8-OHdG and liver TBARS were measured in the Control group. In comparison, the sweet potato foliage extract administration group showed a significantly lower value. Macroscopic observation during dissection showed that the condition was particularly good in the 1 mg / kg group, and the liver weight was also low. Furthermore, the serum biochemical test values were similarly good in the sweet potato shoot extract administration group, and showed a tendency in the 1 mg / kg group rather than the 30 mg / kg group as in the macroscopic observation. In the 30 mg / kg group, serum lipid peroxide and urinary 8-0HdG were lower than in the 1 mg / kg group.
From the above results, the sweet potato foliage extract was found to be obtained in a model animal in which in vivo lipid peroxidation was induced by intraperitoneal administration of the radical initiator AAPH. It exhibits an antioxidant effect that significantly suppresses the production of peroxides such as 8-OHdG in human excreta, and also exhibits a milder antioxidant effect than a high concentration when consumed at low concentrations, and reduces liver damage. It was confirmed that the material has a protective effect.
(Discussion on the above results)
The above experimental results were indeed surprising. In other words, the polyphenols in the sweet potato stem and leaf extract used here are about 30% in terms of catechin, and 0.3 × 1 mg / kg × 60 kg = 18 mg in terms of a person weighing 60 kg. As a polyphenol component, it is expected to exhibit functionality with an intake of only about 20 mg per day. On the other hand, when comparing tea catechins that have recently been in the limelight, a value of 500 mg per person has been published as the amount that demonstrates its functionality (Bioscience and Industry Vol. 61 No. 11 2003). The function of tea catechin is to reduce body fat, which is different from the sweet potato stem and leaf extract of the present invention, but our anticipation is that the effective concentration of polyphenol is an order of magnitude lower than tea catechin and is highly active. It was something that exceeded. In addition, the 2004 Agricultural Chemistry Society of Japan reported on the liver dysfunction reduction effect of carbon tetrachloride administration of sweet potato juice containing anthocyanin prepared from purple sweet potato tuberous root from the group of Kyushu Okinawa Agricultural Research Center. The purple sweet potato juice announced contains 12.6 g of purple sweet potato ingredients in 120 ml, and the dosage was 50 mg / kg per day in terms of anthocyanins. It is considered that the functional effect of the product is sufficiently high compared with that (Agricultural Chemistry Society of Japan Annual Meeting 2004, 3A17p10).
Example 10 Confirmation of Tyrosinase Inhibitory Activity
Tyrosinase inhibitory activity was measured using the sweet potato stem and leaf extract obtained in Example 4. The measuring method is shown below.
(A) Reaction reagent
Tyrosine solution (0.5 mg / mL):
Tyrosinase solution (2500 U / mg): 6 mg of mushroom-derived tyrosinase (2500 U / mg) was diluted to 100 mL with distilled water and used for measurement.
-1/15 M phosphate buffer (pH 6.8): Potassium dihydrogen phosphate 0.9072 g distilled water to 100 mL, sodium hydrogen phosphate 2.3876 g was made up to 100 mL with distilled water. Next, after each equal amount was mixed, it was confirmed that the pH was 6.8 and used for measurement.
50% v / v ethanol solution: Ethanol and distilled water were mixed in equal amounts and used for measurement.
(B) Preparation of sample object
10 mg of the sweet potato foliage extract obtained in Example 4 was dissolved in 10 mL of a 50 v / v% ethanol solution to obtain a stock solution. Next, the stock solution was diluted with 1 / 15M phosphate buffer (pH 6.8) to a quantity of 0.005 mg, 0.01 mg, 0.05 mg, 0.1 mg, 0.5 mg, and the reaction Used for.
(C) Tyrosinase activity measurement
After preparing the following reaction system, it was incubated at 37 ° C. for 1 hour, and the absorbance at 475 nm was measured. As a control (Ab), a tyrosine solution (0.5 mL), a phosphate buffer (4.0 mL), and a tyrosinase solution (0.5 mL) are added to make 5.0 mL. On the other hand, the sample (At) is made 5 mL by adding a tyrosine solution (0.5 mL), a phosphate buffer (2.0 mL), a tyrosinase solution (0.5 mL), and each test solution (2.0 mL).
(D) The tyrosinase activity inhibition rate was calculated using the following formula.
Inhibition rate = (Ab−At) / Ab × 100
In addition,
The tyrosinase inhibitory activity of the sweet potato stem and leaf extract was measured in comparison with kojic acid and ascorbic acid, which have known whitening effects. The results are shown in Table 5.
Example 11 Confirmation of sugar absorption inhibitory effect
The sugar tolerance test by glucose administration was performed about the sugar absorption suppression effect in the animal experiment using the sweet potato foliage extract obtained in Example 4. The test materials and methods are shown below.
(A) Test animal
Species: Rat, Strain: SD, Gender: Male, Age at arrival: 4 weeks old
(B) Test group setting
Control group: 5 animals, 30 mg / kg administration group: 5 animals
(C) Test items and methods
-The body weight was measured between 10 am and 11 am every day only during the pre-breeding period. In addition, the glucose tolerance test was divided into four groups in consideration of the weight of the previous day.
-The sweet potato stem and leaf extract was adjusted to each concentration with distilled water and orally administered using a stomach tube.
・ Glucose tolerance test was fasted for 18 hours from the day before the test, glucose was orally administered at 2 g / kg, blood was collected from the orbital venous plexus before administration (0 minutes), 30, 60, 90, and 120 minutes after administration, and blood glucose was measured. Measured using a machine. The sweet potato shoot extract was administered 30 minutes before glucose load. In addition, a Δblood glucose area value (AUC: mg / dL · hr) for 120 minutes was calculated from the following calculation formula based on each measurement value.
a formula
AUC (0-T4) = C1T1 / 2 + (C1 + C2) (T2-T1) / 2 + (C2 + C3) (T3-T2) / 2 + (C3 + C4) (T4-T3) / 2
C1: Increase in blood glucose from 0 to 30 minutes
C2: Blood sugar elevation from 0 to 60 minutes
C3: Blood sugar elevation from 0 to 90 minutes
C4: Blood sugar elevation from 0 to 120 minutes
T: Elapsed time (hr) T1: 0.5 hr, T2: 1.0 hr, T3: 1.5 hr, T4: 2.0 hr
As a statistical process, the test result is expressed as an average value ± standard error, and the Student's-t test is used for the significant difference test.
The results of the sugar tolerance test of the sweet potato stem and leaf extract are shown in Table 6.
Further, under the same conditions as described above, a comparative test with guava leaf extract was performed for the effect of suppressing blood sugar elevation. The test groups were a sweet potato foliage extract 30 mg / kg group, a 100 mg / kg group, a
Similarly to the above, after administering the test subject, 2 g / kg of glucose was orally administered, blood was collected according to the same blood collection schedule as above, and the blood glucose level was measured. A graph of blood glucose concentration over time based on each measured value is shown in FIG.
At 30 minutes after glucose administration, the blood glucose level increased most in all groups, but the sweet potato stalk-and-leaf extract group and the guava leaf extract group had a gentle slope of the increase in blood glucose level compared to the control group, It was inferred that each group suppressed sugar absorption. The sweet potato foliage extract 30 mg / kg group showed the same level of blood glucose level as the
Example 12 Confirmation of fat absorption inhibitory action
A fat tolerance test by administration of soybean oil was conducted for the fat absorption inhibitory effect in animal experiments using the sweet potato foliage extract obtained in Example 4. The test materials and methods are shown below.
(A) Test animal
Species: Rat, Strain: SD, Gender: Male, Age at arrival: 4 weeks old
(B) Test group setting
Control group: 5 animals, 30 mg / kg administration group: 5 animals
(C) Test items and methods
-The body weight was measured between 10 am and 11 am every day only during the pre-breeding period. In addition, the fat tolerance test divided into 4 groups in consideration of the body weight of the previous day.
-The sweet potato stem and leaf extract was adjusted to each concentration with distilled water and orally administered using a stomach tube.
・ Fat tolerance test was fasted for 18 hours from the day before the test, followed by oral administration of 2 g / kg of vegetable (soybean) oil, and orbiting before administration (0 minutes) and 30, 60, 120, 180, 240, 300 minutes after administration. Blood was collected from the venous plexus. The blood was centrifuged (4 ° C., 3000 rpm, 20 minutes) to collect plasma, and the triglyceride concentration was measured using a commercially available kit. The sweet potato shoot extract was administered immediately before the vegetable oil administration. Moreover, (DELTA) neutral fat area value (AUC: mg / dL * hr) for 300 minutes was computed from the following formula based on each measured value.
a formula
AUC (0-T4) = C1T1 / 2 + (C1 + C2) (T2-T1) / 2 + (C2 + C3) (T3-T2) / 2 + (C3 + C4) (T4-T3) / 2 + (C4 + C5) (T5-T4) / 2 + (C5 + C6) (T6-T5) / 2
C1: Triglyceride increase from 0 to 30 minutes
C2: Triglyceride increase from 0 to 60 minutes
C3: Triglyceride increase from 0 to 120 minutes
C4: Triglyceride increase from 0 to 180 minutes
C5: Triglyceride increase from 0 to 240 minutes
C6: Triglyceride increase from 0 to 300 minutes
T: Elapsed time (hr) T1: 0.5 hr, T2: 1.0 hr, T3: 2 hr, T4: 3 hr, T5: 4 hr, T6: 5 hr
As a statistical process, the test result is expressed as an average value ± standard error, and the Student's-t test is used for the significant difference test.
Table 7 shows the results of the fat tolerance test of the sweet potato stem and leaf extract.
At 180 minutes and 240 minutes after the vegetable oil administration, the sweet potato shoot extract administration group showed a lower value than the control group, and a significant difference was also observed at 180 minutes. There was no difference between groups after 300 minutes. From the above, in addition to confirming the fat absorption inhibitory action of the sweet potato stem and leaf extract, there is a possibility of having an absorption delaying action.
Further, under the same conditions as described above, a comparison test with a green tea extract (
mg / dL · hr) was calculated as described above and is shown in FIG.
The sweet potato stem and leaf extract administration group and the green tea extract (
Example 13 Toxicity Test of Sweet Potato Forage Extract
To examine the oral toxicity of a single administration of the sweet potato foliage extract obtained in Example 4, at a dose of 0 mg / kg (control group) and 2000 mg / kg, once for each 5 male and female SD rats per dose. And observed for 14 days. A predetermined amount of a sweet potato shoot extract was weighed and suspended in a 2 v /
Example 14 Production of drinking water (hot water extract) containing sweet potato leaf extract
By adding a roasting step, the sweet potato foliage extract can be tasted in a range that retains the antioxidant properties of the sweet potato foliage extract. It is possible to adjust the degree of roasting by adjusting the roasting temperature and time.
A sweet potato leaf (dried product) cut with a cutting machine, roasted moderately (2
Example 15 Mutagenicity test of sweet potato stem and leaf extract
(1) Ames test
The effect of mutagenicity in vitro was determined by the “Ames test” in accordance with the Guidelines for Drug Genotoxicity Testing. Five strains of Salmonella typhimurium (TA100, TA98, TA1535, TA1537) and Escherichia coli (WP2uvrA / pKM101) were used as assay bacteria. The sweet potato foliage extract (test sample) 5000 μg / plate obtained in Example 4 was used as the highest dose, and a dose response test was conducted in 6 steps (1.22 to 500) for each of the S9mix addition and non-addition groups. Since no growth inhibition of the fungus was observed, this test was also carried out with 5 doses set at 5000 μg / plate as the maximum dose, and the number of revertant colonies at each concentration was measured. As a result, according to the determination method of the Ames test, mutagenicity was determined to be negative regardless of the presence or absence of S9mix in any of the test bacteria.
(2) Micronucleus test
The in vivo mutagenic effect of the sweet potato stem and leaf extract was determined by the “micronucleus test using rodents” in accordance with the Guidelines for Drug Genotoxicity Testing. The sweet potato foliage extract (test sample) 500, 1000, and 2000 mg / kg obtained in Example 4 was administered twice orally to male rats (7 weeks of age, 5 animals / group) using three doses each (24 As a result of the time interval, there was no death in any group, and there was no change in the general condition. Therefore, in this test, the test sample was set to the same concentration, and
The above results indicate that the mutagenicity of the sweet potato foliage extract was negative in all tests, suggesting that the ingestion of the sweet potato foliage extract is unlikely to cause mutation and is extremely safe. .
Example 16 Deodorizing effect test of sweet potato stem and leaf extract
We examined the deodorizing effect on causative substances such as bad breath, body odor, and fecal odor of humans and pets.
(1) Ammonia, trimethylamine, and mercaptan were added to 100 ml pure water in a 300 ml conical beaker, and the lid was covered with aluminum foil.
(2) The concentration of each component in the headspace portion was measured with a detector tube, 1 g of the sweet potato shoot extract obtained in Example 4 was added and stirred, and the concentration of each component in the headspace portion was measured with a detector tube. .
The measurement results are shown in FIG. As for ammonia and trimethylamine, no odor was felt immediately after adding the sweet potato shoot extract, and the concentrations were below the detection limit. In addition, methyl mercaptan was partially decomposed immediately after the addition of the sweet potato shoot extract, and a deodorizing effect was observed. From the above, it was suggested that the sweet potato shoot extract exerts a deodorizing effect on different kinds of odors. Since the sweet potato stem and leaf extract has been confirmed to be extremely safe for living bodies by the safety test of the present invention, it eliminates bad breath, body odor and fecal odor of humans and pets, and deodorizes food and drink. Among substances having a deodorizing effect, it can be said that the substance can be used in a very wide range of applications.
Example 17 Adipocyte differentiation and hypertrophy inhibition test using rat white adipocytes
In order to examine the effect of suppressing the increase in adipocytes, a test for suppressing differentiation and hypertrophy of white adipocytes derived from rat mesentery in vitro was performed.
Observation of adipocyte differentiation and suppression of hypertrophy in rat white adipocytes
The fat cells of the rat white fat cell kit (Cell Garage Co., Ltd.) were used, and all operations were performed according to the usual method. First, adipocytes are grown in growth medium with 5% CO2.2Incubation was carried out for 24 hours. 2 × 10 fat cells5After inoculating into a 24 well plate so as to be cells / well and incubating for 24 hours, the medium is replaced with a differentiation-inducing medium, and 5
The states after 24 hours, 72 hours and 96 hours of each group of adipocytes are shown in FIG. As a result, the sweet potato stem and leaf extract and the green tea extract both remarkably suppressed the accumulation of fat cell fat droplets and fat cell hypertrophy over all times compared to the control. Comparing the sweet potato stem and leaf extract with the green tea extract, the accumulation of lipid droplets in the green tea extract was slightly less after 24 hours, but both were the same after 48 hours (data not shown) and after 72 hours. After the time, the sweet potato foliage extract was the same or slightly suppressed the fat cell hypertrophy. From the above, it was found that the sweet potato stem and leaf extract has substantially the same or higher effect of suppressing adipocyte differentiation and hypertrophy than the green tea extract. Therefore, it was suggested that the sweet potato shoot extract of the present invention can be used as a prophylactic / therapeutic agent for obesity caused by adipocyte differentiation and hypertrophy.
Example 18 Examination of antidepressant action and anti-fatigue action by mouse forced swimming method
We investigated the antidepressant action and anti-fatigue action of sweet potato stem and leaf extract by forced swimming of mice.
Mice (BALB / c strain, male, 7 weeks old) were acclimated by preliminary breeding for 7 days until the day before the start of this test. 2 days before the end of the pre-breeding, the test animals are forced to swim for 5 minutes and screened so that the swimming state before administration of the test object is uniform. The test was started after grouping. The test groups were the sweet potato leaf extract 30 mg / kg group, the 300 mg / kg group, the St. John's wort 300 mg / kg, and the subject group obtained in Example 4. Each test object was prepared in physiological saline and administered by oral gavage (10 mL / kg) using a stomach tube. For the control group, physiological saline was similarly administered by gavage (10 mL / kg). One hour after administration of the test object, swimming was performed in an acrylic water tank (350 × 400 × 180 mm) filled with 10 L of warm water (37 ° C.), and the swimming state was observed. The determination was made by measuring the duration according to the following criteria.
Judgment criteria
EDB (escape directed behavior): An action to jump out of a water tank or an action to search for an exit by diving
IMO (Immobility): The state where most movements are stopped and only floating
The average values of EDB and IMO time for each group are shown in FIG. In the sweet potato foliage extract and St. John's wort extract administration groups, a significant increase in EDB and a significant shortening of IMO were observed with respect to the control group. Further, the sweet potato foliage extract administration group showed a concentration-dependent effect, and the sweet
Example 19 Oil stability test
The sweet potato foliage extract obtained in Example 4 was added to 3 g of pork fat free of vitamin E so as to be 200 ppm and 1000 ppm, respectively, and used as a sample solution. The deterioration start time of fats and oils was calculated | required by the automatic oil-fat stability test apparatus (CDM test apparatus) with the dry air flow rate of 20 L / hr and the temperature of 120 degreeC.
The deterioration time in the concentration of sweet potato stem and leaf extract is shown in FIG. The sweet potato stem and leaf extract extended the deterioration time of 1.6 hours at 0 ppm, doubled the deterioration time of pork fat at 200 ppm, and tripled it at 1000 ppm (5 hours). Extended. From the above, sweet potato stem and leaf extract is added to processed foods (fried potatoes, snacks, cup noodles, etc.) that use animal lipids such as pork fat and lard and other various fats and oils, and is applied to prevent fat and oil deterioration It was suggested that this could be done.
Example 20 Preparation of a preparation using a sweet potato shoot extract
The following three types of preparations were prepared using the sweet potato stem and leaf extract of the present invention.
(1) Preparation of granules
As shown in Table 8 below, the sweet potato foliage extract is mixed with various excipients to a final concentration of 5%, and a total amount of 2 kg of raw materials are added and kneaded, and then the spray drying granulator is used. Granules were prepared using these. The produced granules were packaged in aluminum every 2 grams. Since this product is convenient to carry and has good water solubility, it can be made into a delicious beverage by dissolving in about 100 mL of hot water or water at the time of use. This product contains 100 mg of sweet potato stover extract per packet.
As shown in Table 9 below, 1 kg of sweet potato foliage extract is mixed with various excipients so that the final concentration is 20%, and after adding a suitable amount of water based on a total of 5 kg of raw materials, kneading and pressing A tablet of 250 mg was prepared using a tablet manufacturing machine. This product contains 50 mg of sweet potato stover extract per tablet.
As shown in Table 10 below, 10 g of sweet potato stem and leaf extract is mixed with 1 kg of gummy base under heating, and boiled until the sugar content reaches about 80%. A citric acid solution and fruit juice and flavor were added, and the resulting mixture was molded into 5 g per grain while hot (sweet potato stem and leaf extract final concentration 0.1%). This product contains 5 mg of sweet potato stem and leaf extract per grain.
本発明によれば、人体に種々の有益な活性を有するポリフェノール類を含有する水溶性サツマイモ茎葉抽出物を提供することができる。本発明のサツマイモ茎葉抽出物は、抗酸化活性、チロシナーゼ阻害活性、肝保護作用、糖や中性脂肪の吸収抑制作用等の活性又は作用を有するので、そのような機能・作用を有する機能性食品、機能性素材、医薬等として有用である。
また、本発明のポリフェノール含有サツマイモ茎葉抽出物の製造方法によれば、特別な材料や施設を用いることなく効率良くポリフェノール含有抽出物を得ることができる。ADVANTAGE OF THE INVENTION According to this invention, the water-soluble sweet potato stem and leaf extract containing the polyphenol which has various beneficial activity for a human body can be provided. The sweet potato stem and leaf extract of the present invention has activities or actions such as antioxidant activity, tyrosinase inhibitory activity, hepatoprotective action, sugar or neutral fat absorption inhibitory action, etc., so a functional food having such functions and actions It is useful as a functional material, medicine and the like.
Moreover, according to the method for producing a polyphenol-containing sweet potato foliage extract of the present invention, a polyphenol-containing extract can be efficiently obtained without using special materials or facilities.
Claims (29)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004231365 | 2004-08-06 | ||
JP2004231365 | 2004-08-06 | ||
PCT/JP2005/014799 WO2006014028A1 (en) | 2004-08-06 | 2005-08-05 | Sweet potato stem extract and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2006014028A1 true JPWO2006014028A1 (en) | 2008-05-01 |
Family
ID=35787298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006531750A Pending JPWO2006014028A1 (en) | 2004-08-06 | 2005-08-05 | Sweet potato stem and leaf extract and use thereof |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2006014028A1 (en) |
WO (1) | WO2006014028A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8138162B2 (en) | 2004-06-04 | 2012-03-20 | Horizon Science Pty Ltd. | Natural sweetener |
JP2008208030A (en) * | 2005-04-27 | 2008-09-11 | Toyo Shinyaku:Kk | Inhibitor for lipid accumulation in liver |
JP5311708B2 (en) * | 2005-08-12 | 2013-10-09 | 国立大学法人佐賀大学 | Method for extracting polyphenols containing tricaffeoylquinic acid |
JP4856471B2 (en) * | 2006-05-18 | 2012-01-18 | 花王株式会社 | Tetrahydrobiopterin production promoter |
JP2010503417A (en) | 2006-09-19 | 2010-02-04 | ホリズン サイエンス ピーティーワイ リミテッド | Extracts derived from sugarcane and methods for producing them |
JP4621855B2 (en) * | 2007-01-17 | 2011-01-26 | 雲海酒造株式会社 | Liver protective agent, hepatocarcinogenesis inhibitor, and pharmaceutical compositions thereof |
JP5276316B2 (en) * | 2007-12-28 | 2013-08-28 | サントリーホールディングス株式会社 | Composition containing sesamin and quercetin glycoside |
WO2010039024A1 (en) * | 2008-09-30 | 2010-04-08 | Universiti Putra Malaysia | A composition for wound healing |
WO2012106761A1 (en) | 2011-02-08 | 2012-08-16 | Horizon Science Pty Ltd | Sugar extracts |
AU2012266308B2 (en) | 2011-06-07 | 2016-05-19 | Centre De Cooperation Internationale En Recherche Agronomique Pour Le Developpement | Composition comprising cashew apple extract |
JP6062783B2 (en) * | 2012-05-24 | 2017-01-18 | 花王株式会社 | Method for producing polyphenol composition |
CN102697058A (en) * | 2012-06-13 | 2012-10-03 | 山东省农业科学院农产品研究所 | Preparation method of sweet potato stem-leaf extract |
JP6239622B2 (en) | 2012-08-28 | 2017-11-29 | ザ プロダクト メーカーズ (オーストラリア) プロプライエタリー リミテッド | Extraction method |
JP2014070056A (en) * | 2012-09-28 | 2014-04-21 | Oriza Yuka Kk | Fat accumulation inhibitor |
EP2968431A4 (en) * | 2013-03-15 | 2016-11-02 | Univ Georgia State Res Found | Compositions derived from sweet potato greens and methods of preparation and use |
JP6145819B2 (en) * | 2013-07-08 | 2017-06-14 | 晨星興産株式会社 | Process for producing polyphenol extract concentrate using sweet potato stems and leaves |
JP2015036370A (en) * | 2013-08-13 | 2015-02-23 | 晨星興産株式会社 | Hair restoration composition using sweet potato polyphenol extract |
WO2015021512A1 (en) | 2013-08-16 | 2015-02-19 | Horizon Science Pty Ltd | Sugar cane derived extracts and methods of treatment |
KR101595903B1 (en) * | 2015-09-10 | 2016-02-19 | 영주농업회사법인 주식회사 | The manufacturing method dried sweet potato and dried sweet potato |
FR3047171A1 (en) * | 2016-01-29 | 2017-08-04 | Plant Advanced Tech Pat | DIPROPYLENE GLYCOL ESTERS OF DICAFEOYLQUINIC ACIDS, VEGETABLE EXTRACT CONTAINING SAME, PROCESS FOR OBTAINING THE SAME AND USES THEREOF |
JP6608874B2 (en) * | 2017-06-15 | 2019-11-20 | 株式会社東洋新薬 | Beauty composition |
JP6906248B2 (en) * | 2017-06-15 | 2021-07-21 | 株式会社東洋新薬 | Cosmetology composition |
JP2019043862A (en) * | 2017-08-30 | 2019-03-22 | キリン株式会社 | Composition for mitigating fatigue feeling and improving stiffness |
KR102607239B1 (en) * | 2018-01-15 | 2023-11-29 | 한국식품연구원 | Composition comprising as an active ingredient a sweet potato extract |
CN110959716A (en) * | 2019-11-22 | 2020-04-07 | 北京农业职业学院 | Sweet potato leaf green tea preparation method and sweet potato leaf green tea |
CN112106989A (en) * | 2020-09-07 | 2020-12-22 | 中国农业科学院农产品加工研究所 | Sweet potato stem leaf polyphenol and extraction method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002047196A (en) * | 1993-12-06 | 2002-02-12 | Nikka Whisky Distilling Co Ltd | Fruit polyphenol, antioxidant, hypotensive agent, antimutagenic agent, allergic inhibitor, cariostatic agent and deodorant |
JP2003034636A (en) * | 2001-07-19 | 2003-02-07 | Kao Corp | Lipid metabolism-improving agent |
JP2004075638A (en) * | 2002-08-21 | 2004-03-11 | Okinawa Pref Gov | Functional material having action to suppress increase of blood sugar level and suppress increase of blood pressure |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4336746B2 (en) * | 2003-05-30 | 2009-09-30 | 田苑酒造株式会社 | Method for producing caffeic acid |
-
2005
- 2005-08-05 JP JP2006531750A patent/JPWO2006014028A1/en active Pending
- 2005-08-05 WO PCT/JP2005/014799 patent/WO2006014028A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002047196A (en) * | 1993-12-06 | 2002-02-12 | Nikka Whisky Distilling Co Ltd | Fruit polyphenol, antioxidant, hypotensive agent, antimutagenic agent, allergic inhibitor, cariostatic agent and deodorant |
JP2003034636A (en) * | 2001-07-19 | 2003-02-07 | Kao Corp | Lipid metabolism-improving agent |
JP2004075638A (en) * | 2002-08-21 | 2004-03-11 | Okinawa Pref Gov | Functional material having action to suppress increase of blood sugar level and suppress increase of blood pressure |
Also Published As
Publication number | Publication date |
---|---|
WO2006014028A1 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2006014028A1 (en) | Sweet potato stem and leaf extract and use thereof | |
JP4644787B2 (en) | Anti-obesity agent having lipase inhibitory activity and antioxidant properties | |
Shehata et al. | Effects of bioactive component of kiwi fruit and avocado (fruit and seed) on hypercholesterolemic rats. | |
KR20060115767A (en) | Physiologically functional drinks and compositions | |
US20150201661A1 (en) | Bamboo extracts, compositions and uses thereof | |
JP4358957B2 (en) | Agent for scavenging or reducing free radicals or active oxygen | |
Niazi et al. | Date palm: composition, health claim and food applications | |
Kumar et al. | Underutilized citrus species: An insight of their nutraceutical potential and importance for the development of functional food | |
Lye et al. | Avocado | |
JP2007145753A (en) | Lipase inhibitor | |
JP2008214191A (en) | Agent for suppressing accumulation of lipid in liver | |
KR100549193B1 (en) | Foods comprising ginseng and powders or extracts of plants comprising polyphenol or bioflavonoid for suppressing the fatness | |
JP2006063038A (en) | Antiaging composition, cosmetic containing the same, and food and drink containing the same | |
JP5309292B2 (en) | Lipase inhibitor | |
JP3568891B2 (en) | Food and drink containing olive extract | |
JP2010159283A (en) | Proanthocyanidin-containing composition | |
KR102512796B1 (en) | Extract of Molokhia with high antioxidant effect, and use thereof | |
JP2008163003A (en) | Fat absorption inhibitor | |
KR20140036966A (en) | Composition for improving exercise capacity or a composition for reducing fatigue using leaves of sasa quelpaertensis | |
Lal et al. | Traditional, medicinal and nutraceutical values of minor fruit: Longan | |
Marnewick | Antioxidant Properties of Rooibos (Aspalathus linearis)—In Vitro and in Vivo Evidence | |
KR100416650B1 (en) | Extract Polygonatum and composition caontaining the same with hypocholesterolemic and hypoglycemic activities | |
KR20170072055A (en) | An antioxidant composition comprising the pachyrhizus erosus root bark extract | |
JP2020176093A (en) | Blood triglyceride elevation inhibitor containing processed morus leaves | |
KR100656241B1 (en) | The extract of Korean fermented soybean with inhibitory effect on hyperlipemia and platelet aggregation, and their composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080627 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110830 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120124 |